#BEGIN_DRUGCARD DB01752

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
979-92-0

# ChEBI_ID:
16680

# Chemical_Formula:
C14H20N6O5S

# Chemical_IUPAC_Name:
(2S)-2-amino-4-({[(2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}sulfanyl)butanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
5&#39;-S-(3-Amino-3-carboxypropyl)-5&#39;-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
S-Adenosyl-L-Homocysteine

# HET_ID:
SAH

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C14H20N6O5S/c15-6(14(23)24)1-2-26-3-7-9(21)10(22)13(25-7)20-5-19-8-11(16)17-4-18-12(8)20/h4-7,9-10,13,21-22H,1-3,15H2,(H,23,24)(H2,16,17,18)/t6-,7-,9-,10+,13+/m0/s1

# InChI_Key:
InChIKey=ZJUKTBDSGOFHSH-SRMDEQNCSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00021

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1752

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
384.411

# Molecular_Weight_Mono:
384.12158847

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1EQA

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.4

# Predicted_LogS:
-2

# Predicted_Water_Solubility:
4.08e+00 g/l

# Primary_Accession_No:
DB01752

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936206

# PubChem_Substance_ID:
46508993

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02842

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@@H](CCSC[C@@H]1O[C@H]([C@H](O)[C@H]1O)N1C=NC2=C1N=CN=C2N)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:27 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Phase_1_Metabolizing_Enzyme_1_Gene_Name:
HNMT

# Phase_1_Metabolizing_Enzyme_1_ID:
4203

# Phase_1_Metabolizing_Enzyme_1_Name:
Histamine N-methyltransferase

# Phase_1_Metabolizing_Enzyme_1_Protein_Sequence:
>Histamine N-methyltransferase
MASSMRSLFSDHGKYVESFRRFLNHSTEHQCMQEFMDKKLPGIIGRIGDTKSEIKILSIG
GGAGEIDLQILSKVQAQYPGVCINNEVVEPSAEQIAKYKELVAKTSNLENVKFAWHKETS
SEYQSRMLEKKELQKWDFIHMIQMLYYVKDIPATLKFFHSLLGTNAKMLIIVVSGSSGWD
KLWKKYGSRFPQDDLCQYITSDDLTQMLDNLGLKYECYDLLSTMDISDCFIDGNENGDLL
WDFLTETCNFNATAPPDLRAELGKDLQEPEFSAKKEGKVLFNNTLSFIVIEA

# Phase_1_Metabolizing_Enzyme_1_SwissProt_ID:
P50135

# Drug_Target_10_Cellular_Location:
Not Available

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_10_Essentiality:
Non-Essential

# Drug_Target_10_GenAtlas_ID:
Not Available

# Drug_Target_10_GenBank_ID_Gene:
Not Available

# Drug_Target_10_GenBank_ID_Protein:
Not Available

# Drug_Target_10_GeneCard_ID:
Not Available

# Drug_Target_10_Gene_Name:
PRMT3

# Drug_Target_10_Gene_Sequence:
Not Available

# Drug_Target_10_General_Function:
Not Available

# Drug_Target_10_General_References:
Not Available

# Drug_Target_10_HGNC_ID:
Not Available

# Drug_Target_10_HPRD_ID:
Not Available

# Drug_Target_10_ID:
6956

# Drug_Target_10_Locus:
Not Available

# Drug_Target_10_Molecular_Weight:
Not Available

# Drug_Target_10_Name:
Protein arginine N-methyltransferase 3

# Drug_Target_10_Number_of_Residues:
0

# Drug_Target_10_PDB_ID:
Not Available

# Drug_Target_10_Pathway:
Not Available

# Drug_Target_10_Pfam_Domain_Function:
Not Available

# Drug_Target_10_Protein_Sequence:
Not Available

# Drug_Target_10_Reaction:
Not Available

# Drug_Target_10_Signals:
Not Available

# Drug_Target_10_Specific_Function:
Not Available

# Drug_Target_10_SwissProt_ID:
O60678

# Drug_Target_10_SwissProt_Name:
ANM3_HUMAN

# Drug_Target_10_Synonyms:
Not Available

# Drug_Target_10_Theoretical_pI:
Not Available

# Drug_Target_10_Transmembrane_Regions:
Not Available

# Drug_Target_11_Cellular_Location:
Cytoplasm

# Drug_Target_11_Chromosome_Location:
Not Available

# Drug_Target_11_Drug_References:
Not Available

# Drug_Target_11_Essentiality:
Non-Essential

# Drug_Target_11_GenAtlas_ID:
HNMT

# Drug_Target_11_GenBank_ID_Gene:
D16224

# Drug_Target_11_GenBank_ID_Protein:
Not Available

# Drug_Target_11_GeneCard_ID:
Not Available

# Drug_Target_11_Gene_Name:
HNMT

# Drug_Target_11_Gene_Sequence:
>879 bp
ATGGCATCTTCCATGAGGAGCTTGTTTTCTGACCACGGGAAATATGTTGAATCTTTCCGG
AGGTTTCTCAACCATTCCACGGAACACCAGTGCATGCAGGAATTCATGGACAAGAAGCTG
CCAGGCATAATAGGAAGGATTGGAGACACAAAATCAGAAATTAAGATTCTAAGCATAGGC
GGAGGTGCAGGTGAAATTGATCTTCAAATTCTCTCCAAAGTTCAGGCTCAATACCCAGGA
GTTTGTATCAACAATGAAGTTGTTGAGCCAAGTGCTGAACAAATTGCCAAATACAAAGAG
CTTGTAGCCAAGACATCGAACCTCGAGAACGTAAAGTTTGCTTGGCATAAGGAGACATCA
TCTGAATACCAAAGTAGAATGTTGGAGAAAAAGGAGCTTCAAAAGTGGGACTTTATTCAT
ATGATTCAAATGCTGTATTATGTAAAAGACATCCCAGCTACCCTGAAATTCTTCCATAGT
CTCTTAGGTACCAATGCTAAGATGCTCATTATTGTTGTGTCAGGAAGCAGTGGCTGGGAC
AAGCTGTGGAAAAAGTACGGATCACGCTTTCCCCAGGATGACCTCTGCCAGTATGTCACA
TCAGATGACCTCACTCAGATGCTGGACAACCTAGGGCTTAAGTATGAGTGCTATGACCTT
TTGTCCACCATGGATATATCTGACTGCTTTATTGATGGTAATGAAAATGGAGACCTGCTT
TGGGATTTTTTGACTGAAACCTGCAACTTTAATGCCACAGCACCACCTGATCTCAGAGCA
GAGCTTGGGAAAGATCTACAAGAGCCTGAATTTAGTGCTAAGAAAGAGGGGAAGGTTCTT
TTTAATAATACTCTGAGTTTCATAGTGATTGAGGCATAA

# Drug_Target_11_General_Function:
Not Available

# Drug_Target_11_General_References:
10803682	Yan L, Galinsky RE, Bernstein JA, Liggett SB, Weinshilboum RM: Histamine N-methyltransferase pharmacogenetics: association of a common functional polymorphism with asthma. Pharmacogenetics. 2000 Apr;10(3):261-6.
7943261	Yamauchi K, Sekizawa K, Suzuki H, Nakazawa H, Ohkawara Y, Katayose D, Ohtsu H, Tamura G, Shibahara S, Takemura M, et al.: Structure and function of human histamine N-methyltransferase: critical enzyme in histamine metabolism in airway. Am J Physiol. 1994 Sep;267(3 Pt 1):L342-9.
8145732	Girard B, Otterness DM, Wood TC, Honchel R, Wieben ED, Weinshilboum RM: Human histamine N-methyltransferase pharmacogenetics: cloning and expression of kidney cDNA. Mol Pharmacol. 1994 Mar;45(3):461-8.
8605025	Aksoy S, Raftogianis R, Weinshilboum R: Human histamine N-methyltransferase gene: structural characterization and chromosomal location. Biochem Biophys Res Commun. 1996 Feb 15;219(2):548-54.
9547362	Preuss CV, Wood TC, Szumlanski CL, Raftogianis RB, Otterness DM, Girard B, Scott MC, Weinshilboum RM: Human histamine N-methyltransferase pharmacogenetics: common genetic polymorphisms that alter activity. Mol Pharmacol. 1998 Apr;53(4):708-17.

# Drug_Target_11_HGNC_ID:
HGNC:5028

# Drug_Target_11_HPRD_ID:
Not Available

# Drug_Target_11_ID:
4203

# Drug_Target_11_Locus:
2q22.1

# Drug_Target_11_Molecular_Weight:
33295

# Drug_Target_11_Name:
Histamine N-methyltransferase

# Drug_Target_11_Number_of_Residues:
292

# Drug_Target_11_PDB_ID:
1JQD

# Drug_Target_11_Pathway:
Not Available

# Drug_Target_11_Pfam_Domain_Function:
Not Available

# Drug_Target_11_Protein_Sequence:
>Histamine N-methyltransferase
MASSMRSLFSDHGKYVESFRRFLNHSTEHQCMQEFMDKKLPGIIGRIGDTKSEIKILSIG
GGAGEIDLQILSKVQAQYPGVCINNEVVEPSAEQIAKYKELVAKTSNLENVKFAWHKETS
SEYQSRMLEKKELQKWDFIHMIQMLYYVKDIPATLKFFHSLLGTNAKMLIIVVSGSSGWD
KLWKKYGSRFPQDDLCQYITSDDLTQMLDNLGLKYECYDLLSTMDISDCFIDGNENGDLL
WDFLTETCNFNATAPPDLRAELGKDLQEPEFSAKKEGKVLFNNTLSFIVIEA

# Drug_Target_11_Reaction:
Not Available

# Drug_Target_11_Signals:
None

# Drug_Target_11_Specific_Function:
Inactivates histamine by N-methylation. Plays an important role in degrading histamine and in regulating the airway response to histamine

# Drug_Target_11_SwissProt_ID:
P50135

# Drug_Target_11_SwissProt_Name:
HNMT_HUMAN

# Drug_Target_11_Synonyms:
EC 2.1.1.8
HMT

# Drug_Target_11_Theoretical_pI:
4.98

# Drug_Target_11_Transmembrane_Regions:
None

# Drug_Target_12_Cellular_Location:
Not Available

# Drug_Target_12_Chromosome_Location:
Not Available

# Drug_Target_12_Drug_References:
Not Available

# Drug_Target_12_Essentiality:
Non-Essential

# Drug_Target_12_GenAtlas_ID:
Not Available

# Drug_Target_12_GenBank_ID_Gene:
AE000512

# Drug_Target_12_GenBank_ID_Protein:
Not Available

# Drug_Target_12_GeneCard_ID:
Not Available

# Drug_Target_12_Gene_Name:
rsmH

# Drug_Target_12_Gene_Sequence:
>900 bp
TCAATCTCCTCCTTCCTCTATCCGCTCCGCTGCGCGCAAACGTCCGCTCCTGGCTCTTGG
ATTTTCTCTTATTTCCTCTTCTGAAGGACGAACAGGTTTTTCCGTCAATATTCGTAACTT
TTTAGAATTTCTGAACGTCTCTTTGACGATCCTATCCTCCAGAGAATGAAAGGAAATGAC
CACTATTCTGCCACCAGGGTTTAGAAGATCCTCCGCTTTTTTCAGAAATTCTTTCAGATT
TTCAAGTTCTCTGTTGACATAGATTCTTATAGCCTGGAACGTCTTCGTTGCAAAGTGTCT
CTTGCGGCGTCTGATCTCGTAAGATGGAAGCGCTTCTCTCACAGCTTTAACAAGGTCAAG
GGTGGTGTTGAGGGGACGATTTTCAACGATCTTTCGGGCGATTCTCCTTGCGAATCTCTT
TTCTTCACCGTACTCAAAGATTATCCTCGCTAACTCCTCTTCCGGTAACTCATTCAATAC
CTTTTGAGCCGTTACTTCGCTTTCCAGATCCATACGCATATCCAGTGGTTCTTCTCTCTC
GAACGTGAATCCCCGATTCTCTCCTTTGAGTTGATAAGTAGAAACCCCAAGATCCATTAA
TATCCCATCTACTTTTTCTATTCCTAAAGTTTTAAGAAGAAAATCCGCTTCTCTGTAGGA
GACTTTGAACAAACTCACACGATCTGAGAATTCTTTCAATTTCTCTTCTGCGATCCGCAA
AACTTCTGAATCAACGTCTATTCCTATGATTCTGCATCCCGGACAGTGTTCCAAAATCGC
TCTAGAGTGTCCTCCTTCACCTACCGTGCAATCGAGGATGATTTTCTCATCCTCCGGTTT
CAGAAACTCAATAACTTCTCTAACCATTACAGGAATATGTCGCTGCGAATATTTCCGCAT

# Drug_Target_12_General_Function:
Involved in methyltransferase activity

# Drug_Target_12_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.

# Drug_Target_12_HGNC_ID:
Not Available

# Drug_Target_12_HPRD_ID:
Not Available

# Drug_Target_12_ID:
4309

# Drug_Target_12_Locus:
Not Available

# Drug_Target_12_Molecular_Weight:
34894

# Drug_Target_12_Name:
S-adenosyl-L-methionine-dependent methyltransferase mraW

# Drug_Target_12_Number_of_Residues:
299

# Drug_Target_12_PDB_ID:
1N2X

# Drug_Target_12_Pathway:
Not Available

# Drug_Target_12_Pfam_Domain_Function:
PF01795	Methyltransf_5

# Drug_Target_12_Protein_Sequence:
>S-adenosyl-L-methionine-dependent methyltransferase mraW
MRKYSQRHIPVMVREVIEFLKPEDEKIILDCTVGEGGHSRAILEHCPGCRIIGIDVDSEV
LRIAEEKLKEFSDRVSLFKVSYREADFLLKTLGIEKVDGILMDLGVSTYQLKGENRGFTF
EREEPLDMRMDLESEVTAQKVLNELPEEELARIIFEYGEEKRFARRIARKIVENRPLNTT
LDLVKAVREALPSYEIRRRKRHFATKTFQAIRIYVNRELENLKEFLKKAEDLLNPGGRIV
VISFHSLEDRIVKETFRNSKKLRILTEKPVRPSEEEIRENPRARSGRLRAAERIEEGGD

# Drug_Target_12_Reaction:
Not Available

# Drug_Target_12_Signals:
None

# Drug_Target_12_Specific_Function:
Exhibits S-adenosyl-L-methionine-dependent methyltransferase activity (By similarity)

# Drug_Target_12_SwissProt_ID:
Q9WZX6

# Drug_Target_12_SwissProt_Name:
RSMH_THEMA

# Drug_Target_12_Synonyms:
EC 2.1.1.-

# Drug_Target_12_Theoretical_pI:
8.07

# Drug_Target_12_Transmembrane_Regions:
None

# Drug_Target_13_Cellular_Location:
Not Available

# Drug_Target_13_Chromosome_Location:
Not Available

# Drug_Target_13_Drug_References:
Not Available

# Drug_Target_13_Essentiality:
Non-Essential

# Drug_Target_13_GenAtlas_ID:
Not Available

# Drug_Target_13_GenBank_ID_Gene:
M13761

# Drug_Target_13_GenBank_ID_Protein:
Not Available

# Drug_Target_13_GeneCard_ID:
Not Available

# Drug_Target_13_Gene_Name:
ermC'

# Drug_Target_13_Gene_Sequence:
>735 bp
ATGAACGAGAAAAATATAAAACACAGTCAAAACTTTATTACTTCAAAACATAATATAGAT
AAAATAATGACAAATATAAGATTAAATGAACATGATAATATCTTTGAAATCGGCTCAGGA
AAAGGGCATTTTACCCTTGAATTAGTACAGAGGTGTAATTTCGTAACTGCCATTGAAATA
GACCATAAATTATGCAAAACTACAGAAAATAAACTTGTTGATCACGATAATTTCCAAGTT
TTAAACAAGGATATATTGCAGTTTAAATTTCCTAAAAACCAATCCTATAAAATATTTGGT
AATATACCTTATAACATAAGTACGGATATAATACGCAAAATTGTTTTTGATAGTATAGCT
GATGAGATTTATTTAATCGTGGAATACGGGTTTGCTAAAAGATTATTAAATACAAAACGC
TCATTGGCATTATTTTTAATGGCAGAAGTTGATATTTCTATATTAAGTATGGTTCCAAGA
GAATATTTTCATCCTAAACCTAAAGTGAATAGCTCACTTATCAGATTAAATAGAAAAAAA
TCAAGAATATCACACAAAGATAAACAGAAGTATAATTATTTCGTTATGAAATGGGTTAAC
AAAGAATACAAGAAAATATTTACAAAAAATCAATTTAACAATTCCTTAAAACATGCAGGA
ATTGACGATTTAAACAATATTAGCTTTGAACAATTCTTATCTCTTTTCAATAGCTATAAA
TTATTTAATAAGTAA

# Drug_Target_13_General_Function:
Involved in rRNA (adenine-N6,N6-)-dimethyltransferase activity

# Drug_Target_13_General_References:
10366505	Schluckebier G, Zhong P, Stewart KD, Kavanaugh TJ, Abad-Zapatero C: The 2.2 A structure of the rRNA methyltransferase ErmC' and its complexes with cofactor and cofactor analogs: implications for the reaction mechanism. J Mol Biol. 1999 Jun 4;289(2):277-91.
3087948	Monod M, Denoya C, Dubnau D: Sequence and properties of pIM13, a macrolide-lincosamide-streptogramin B resistance plasmid from Bacillus subtilis. J Bacteriol. 1986 Jul;167(1):138-47.
7543473	Zhong P, Pratt SD, Edalji RP, Walter KA, Holzman TF, Shivakumar AG, Katz L: Substrate requirements for ErmC' methyltransferase activity. J Bacteriol. 1995 Aug;177(15):4327-32.
9585521	Bussiere DE, Muchmore SW, Dealwis CG, Schluckebier G, Nienaber VL, Edalji RP, Walter KA, Ladror US, Holzman TF, Abad-Zapatero C: Crystal structure of ErmC', an rRNA methyltransferase which mediates antibiotic resistance in bacteria. Biochemistry. 1998 May 19;37(20):7103-12.

# Drug_Target_13_HGNC_ID:
Not Available

# Drug_Target_13_HPRD_ID:
Not Available

# Drug_Target_13_ID:
4310

# Drug_Target_13_Locus:
Not Available

# Drug_Target_13_Molecular_Weight:
28908

# Drug_Target_13_Name:
rRNA adenine N-6-methyltransferase

# Drug_Target_13_Number_of_Residues:
244

# Drug_Target_13_PDB_ID:
1QAQ

# Drug_Target_13_Pathway:
Not Available

# Drug_Target_13_Pfam_Domain_Function:
PF00398	RrnaAD

# Drug_Target_13_Protein_Sequence:
>rRNA adenine N-6-methyltransferase
MNEKNIKHSQNFITSKHNIDKIMTNIRLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEI
DHKLCKTTENKLVDHDNFQVLNKDILQFKFPKNQSYKIFGNIPYNISTDIIRKIVFDSIA
DEIYLIVEYGFAKRLLNTKRSLALFLMAEVDISILSMVPREYFHPKPKVNSSLIRLNRKK
SRISHKDKQKYNYFVMKWVNKEYKKIFTKNQFNNSLKHAGIDDLNNISFEQFLSLFNSYK
LFNK

# Drug_Target_13_Reaction:
Not Available

# Drug_Target_13_Signals:
None

# Drug_Target_13_Specific_Function:
This protein produces a dimethylation of the adenine residue at position 2058 in 23S rRNA, resulting in reduced affinity between ribosomes and macrolide-lincosamide-streptogramin B antibiotics

# Drug_Target_13_SwissProt_ID:
P13956

# Drug_Target_13_SwissProt_Name:
ERM_BACSU

# Drug_Target_13_Synonyms:
EC 2.1.1.48
Erythromycin resistance protein
Macrolide- lincosamide-streptogramin B resistance protein

# Drug_Target_13_Theoretical_pI:
10.20

# Drug_Target_13_Transmembrane_Regions:
None

# Drug_Target_14_Cellular_Location:
Nucleus (Probable)

# Drug_Target_14_Chromosome_Location:
Not Available

# Drug_Target_14_Drug_References:
Not Available

# Drug_Target_14_Essentiality:
Non-Essential

# Drug_Target_14_GenAtlas_ID:
TRDMT1

# Drug_Target_14_GenBank_ID_Gene:
AF012128

# Drug_Target_14_GenBank_ID_Protein:
Not Available

# Drug_Target_14_GeneCard_ID:
Not Available

# Drug_Target_14_Gene_Name:
TRDMT1

# Drug_Target_14_Gene_Sequence:
>1176 bp
ATGGAGCCCCTGCGGGTGCTGGAGCTATACAGCGGCGTGGGCGGCATGCACCACGCGCTG
AGAGAAAGCTGTATACCTGCACAAGTGGTGGCTGCCATTGATGTCAACACTGTCGCTAAT
GAAGTATACAAGTATAATTTTCCTCACACACAGTTACTTGCCAAGACGATTGAAGGCATT
ACACTCGAAGAGTTTGACAGATTATCTTTTGATATGATTTTAATGAGCCCTCCCTGCCAG
CCATTCACAAGGATTGGCCGGCAGGGTGATATGACTGATTCAAGGACGAATAGCTTCTTA
CATATTCTAGATATTCTCCCAAGATTACAAAAATTACCAAAGTATATTCTTTTGGAAAAT
GTTAAAGGTTTTGAAGTATCTTCTACAAGAGACCTCTTGATACAAACAATAGAAAATTGT
GGCTTTCAGTACCAAGAATTTCTATTATCTCCAACCTCTCTTGGCATTCCAAATTCAAGG
CTACGATATTTTCTTATTGCAAAGCTTCAGTCAGAGCCATTACCCTTTCAAGCCCCTGGT
CAGGTACTGATGGAGTTCCCCAAAATTGAATCTGTACATCCACAAAAATATGCAATGGAT
GTAGAAAATAAAATTCAAGAAAAGAACGTTGAACCAAATATTAGCTTTGATGGCAGCATA
CAGTGTTCTGGAAAAGATGCCATTCTTTTTAAGCTTGAAACTGCAGAAGAAATTCACAGG
AAAAATCAACAAGATAGTGATCTCTCTGTGAAAATGCTAAAAGATTTTCTTGAAGATGAC
ACTGACGTGAACCAGTATCTTTTACCACCAAAGTCATTGCTGCGATATGCTCTTCTGTTA
GACATTGTTCAGCCCACTTGTAGAAGGTCCGTGTGCTTTACCAAAGGATATGGAAGCTAC
ATAGAAGGGACAGGGTCTGTGTTACAGACTGCAGAGGATGTGCAGGTTGAGAATATCTAC
AAATCCCTTACCAATTTGTCACAAGAAGAACAGATAACAAAGCTGTTAATACTTAAACTG
CGATATTTCACTCCTAAAGAAATAGCAAATCTCCTTGGATTTCCTCCAGAGTTCGGATTT
CCTGAGAAGATAACAGTGAAACAGCGTTATCGCCTACTTGGAAATAGTCTCAACGTGCAT
GTAGTAGCTAAACTAATCAAAATCTTATATGAATAA

# Drug_Target_14_General_Function:
Involved in DNA binding

# Drug_Target_14_General_References:
11139614	Dong A, Yoder JA, Zhang X, Zhou L, Bestor TH, Cheng X: Structure of human DNMT2, an enigmatic DNA methyltransferase homolog that displays denaturant-resistant binding to DNA. Nucleic Acids Res. 2001 Jan 15;29(2):439-48.
11551826	Franchina M, Hooper J, Kay PH: Five novel alternatively spliced transcripts of DNA (cytosine-5) methyltransferase 2 in human peripheral blood leukocytes. Int J Biochem Cell Biol. 2001 Nov;33(11):1104-15.
9425235	Yoder JA, Bestor TH: A candidate mammalian DNA methyltransferase related to pmt1p of fission yeast. Hum Mol Genet. 1998 Feb;7(2):279-84.
9592134	Okano M, Xie S, Li E: Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells. Nucleic Acids Res. 1998 Jun 1;26(11):2536-40.
9599025	Van den Wyngaert I, Sprengel J, Kass SU, Luyten WH: Cloning and analysis of a novel human putative DNA methyltransferase. FEBS Lett. 1998 Apr 17;426(2):283-9.

# Drug_Target_14_HGNC_ID:
HGNC:2977

# Drug_Target_14_HPRD_ID:
Not Available

# Drug_Target_14_ID:
4311

# Drug_Target_14_Locus:
10p15.1

# Drug_Target_14_Molecular_Weight:
44597

# Drug_Target_14_Name:
tRNA

# Drug_Target_14_Number_of_Residues:
391

# Drug_Target_14_PDB_ID:
Not Available

# Drug_Target_14_Pathway:
Not Available

# Drug_Target_14_Pfam_Domain_Function:
PF00145	DNA_methylase

# Drug_Target_14_Protein_Sequence:
>tRNA
MEPLRVLELYSGVGGMHHALRESCIPAQVVAAIDVNTVANEVYKYNFPHTQLLAKTIEGI
TLEEFDRLSFDMILMSPPCQPFTRIGRQGDMTDSRTNSFLHILDILPRLQKLPKYILLEN
VKGFEVSSTRDLLIQTIENCGFQYQEFLLSPTSLGIPNSRLRYFLIAKLQSEPLPFQAPG
QVLMEFPKIESVHPQKYAMDVENKIQEKNVEPNISFDGSIQCSGKDAILFKLETAEEIHR
KNQQDSDLSVKMLKDFLEDDTDVNQYLLPPKSLLRYALLLDIVQPTCRRSVCFTKGYGSY
IEGTGSVLQTAEDVQVENIYKSLTNLSQEEQITKLLILKLRYFTPKEIANLLGFPPEFGF
PEKITVKQRYRLLGNSLNVHVVAKLIKILYE

# Drug_Target_14_Reaction:
Not Available

# Drug_Target_14_Signals:
None

# Drug_Target_14_Specific_Function:
Specifically methylates cytosine 38 in the anticodon loop of tRNA(Asp)

# Drug_Target_14_SwissProt_ID:
O14717

# Drug_Target_14_SwissProt_Name:
TRDMT_HUMAN

# Drug_Target_14_Synonyms:
DNA
DNA MTase homolog HsaIIP
DNA methyltransferase homolog HsaIIP
Dnmt2
EC 2.1.1.29
M.HsaIIP
PuMet
cytosine-5)- methyltransferase-like protein 2
cytosine-5-)-methyltransferase

# Drug_Target_14_Theoretical_pI:
5.95

# Drug_Target_14_Transmembrane_Regions:
None

# Drug_Target_15_Cellular_Location:
Cytoplasm

# Drug_Target_15_Chromosome_Location:
Not Available

# Drug_Target_15_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_15_Essentiality:
Non-Essential

# Drug_Target_15_GenAtlas_ID:
GNMT

# Drug_Target_15_GenBank_ID_Gene:
AF101477

# Drug_Target_15_GenBank_ID_Protein:
8671584

# Drug_Target_15_GeneCard_ID:
GNMT

# Drug_Target_15_Gene_Name:
GNMT

# Drug_Target_15_Gene_Sequence:
>888 bp
ATGGTGGACAGCGTGTACCGGACCCGCTCCCTGGGGGTGGCGGCCGAAGGGCTCCCGGAC
CAGTACGCGGACGGGGAGGCGGCGCGCGTGTGGCAGCTGTATATCGGAGACACCCGCAGC
CGCACCGCCGAGTACAAGGCATGGCTGCTTGGGCTGCTGCGCCAGCACGGCTGCCAGCGG
GTGCTCGACGTAGCCTGTGGCACTGGGGTGGACTCCATTATGCTGGTGGAAGAGGGCTTC
AGTGTGACGAGTGTGGATGCCAGTGACAAGATGCTGAAGTATGCACTTAAGGAGCGCTGG
AACCGGCGGCACGAGCCCGCCTTCGACAAGTGGGTCATCGAAGAAGCCAACTGGATGACT
CTGGACAAAGATGTGCCCCAGTCAGCAGAGGGTGGCTTTGATGCTGTCATCTGCCTTGGA
AACAGTTTCGCTCACTTGCCAGACTGCAAAGGGGACCAGAGTGAGCACCGGCTGGCGCTG
AAAAACATTGCGAGCATGGTGCGGGCAGGGGGCCTACTGGTCATTGATCATCGCAACTAC
GACCACATCCTCAGTACAGGCTGTGCACCCCCAGGGAAGAACATCTACTATAAGAGTGAC
TTGACCAAGGACGTCACAACATCAGTGCTGATAGTGAACAACAAGGCCCACATGGTGACC
CTGGACTATACGGTGCAGGTGCCGGGGGCTGGCCAGGATGGCTCTCCTGGCTTGAGTAAG
TTCCGGCTCTCCTACTACCCACACTGTCTGGCATCCTTCACGGAGCTGCTCCAAGCAGCC
TTCGGAGGTAAGTGCCAGCACAGCGTCCTGGGCGACTTCAAGCCTTACAAGCCAGGCCAA
ACCTACATTCCCTGCTACTTCATCCACGTGCTCAAGAGGACAGACTGA

# Drug_Target_15_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_15_General_References:
10843803	Chen YM, Chen LY, Wong FH, Lee CM, Chang TJ, Yang-Feng TL: Genomic structure, expression, and chromosomal localization of the human glycine N-methyltransferase gene. Genomics. 2000 May 15;66(1):43-7.
11810299	Luka Z, Cerone R, Phillips JA 3rd, Mudd HS, Wagner C: Mutations in human glycine N-methyltransferase give insights into its role in methionine metabolism. Hum Genet. 2002 Jan;110(1):68-74. Epub 2001 Dec 7.
9495250	Chen YM, Shiu JY, Tzeng SJ, Shih LS, Chen YJ, Lui WY, Chen PH: Characterization of glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma. Int J Cancer. 1998 Mar 2;75(5):787-93.

# Drug_Target_15_HGNC_ID:
HGNC:4415

# Drug_Target_15_HPRD_ID:
05970

# Drug_Target_15_ID:
411

# Drug_Target_15_Locus:
6p12

# Drug_Target_15_Molecular_Weight:
32611

# Drug_Target_15_Name:
Glycine N-methyltransferase

# Drug_Target_15_Number_of_Residues:
294

# Drug_Target_15_PDB_ID:
1R74

# Drug_Target_15_Pathway:
Not Available

# Drug_Target_15_Pfam_Domain_Function:
PF08242	Methyltransf_12

# Drug_Target_15_Protein_Sequence:
>Glycine N-methyltransferase
VDSVYRTRSLGVAAEGLPDQYADGEAARVWQLYIGDTRSRTAEYKAWLLGLLRQHGCQRV
LDVACGTGVDSIMLVEEGFSVTSVDASDKMLKYALKERWNRRHEPAFDKWVIEEANWMTL
DKDVPQSAEGGFDAVICLGNSFAHLPDCKGDQSEHRLALKNIASMVRAGGLLVIDHRNYD
HILSTGCAPPGKNIYYKSDLTKDVTTSVLIVNNKAHMVTLDYTVQVPGAGQDGSPGLSKF
RLSYYPHCLASFTELLQAAFGGKCQHSVLGDFKPYKPGQTYIPCYFIHVLKRTD

# Drug_Target_15_Reaction:
S-adenosyl-L-methionine + glycine = S-adenosyl-L-homocysteine + sarcosine

# Drug_Target_15_Signals:
None

# Drug_Target_15_Specific_Function:
Catalyzes the methylation of glycine by using S- adenosylmethionine (AdoMet) to form N-methylglycine (sarcosine) with the concomitant production of S-adenosylhomocysteine (AdoHcy). Possible crucial role in the regulation of tissue concentration of AdoMet and of metabolism of methionine

# Drug_Target_15_SwissProt_ID:
Q14749

# Drug_Target_15_SwissProt_Name:
GNMT_HUMAN

# Drug_Target_15_Synonyms:
EC 2.1.1.20

# Drug_Target_15_Theoretical_pI:
7.03

# Drug_Target_15_Transmembrane_Regions:
None

# Drug_Target_16_Cellular_Location:
Cytoplasmic

# Drug_Target_16_Chromosome_Location:
Not Available

# Drug_Target_16_Drug_References:
Not Available

# Drug_Target_16_Essentiality:
Non-Essential

# Drug_Target_16_GenAtlas_ID:
Not Available

# Drug_Target_16_GenBank_ID_Gene:
L42023

# Drug_Target_16_GenBank_ID_Protein:
Not Available

# Drug_Target_16_GeneCard_ID:
Not Available

# Drug_Target_16_Gene_Name:
trmL

# Drug_Target_16_Gene_Sequence:
>483 bp
TTATTTTACTTCTGGTAAATTTACCGCACCTTTATAGCCTAATTGTCGCCACGCTTCATA
AACCGTTACTGCAACAGAATTAGACAAGTTCATACTGCGGCTATTGGCAGTCATTGGAAT
GCGGATTTTTTGTTCCATCGGCATTTCATTTAAAATTGACATCGGAATGCCACGAGTTTC
TGGGCCAAACATTAAATAATCCCCAAGTTTAAATTTCACTTGGCTATGTGCTGGACAGCC
TTTTGTTGTAAGTGCAAAAAGGCGTTTGGGTTTTTCGCTTTCTAAAAAGGCTTCAAAGGT
TTTGTGGCGTTTGATTTCCGCAAATTCGTGATAATCCAAACCTGAGCGGCGTAAGCGTTT
ATCATCCCAAGTGAAACCTAGTGGTTCAATTAAGTGCAAGCGAAATCCTGTGTTGGCACA
AAGTCGAATAATGTTACCAGTATTTTGTGGGATTTCTGGTTCATATAAAACGATATCTAA
CAT

# Drug_Target_16_General_Function:
Involved in RNA methyltransferase activity

# Drug_Target_16_General_References:
7542800	Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM, et al.: Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science. 1995 Jul 28;269(5223):496-512.

# Drug_Target_16_HGNC_ID:
Not Available

# Drug_Target_16_HPRD_ID:
Not Available

# Drug_Target_16_ID:
4313

# Drug_Target_16_Locus:
Not Available

# Drug_Target_16_Molecular_Weight:
18402

# Drug_Target_16_Name:
Probable tRNA/rRNA methyltransferase HI0766

# Drug_Target_16_Number_of_Residues:
160

# Drug_Target_16_PDB_ID:
1MXI

# Drug_Target_16_Pathway:
Not Available

# Drug_Target_16_Pfam_Domain_Function:
PF00588	SpoU_methylase

# Drug_Target_16_Protein_Sequence:
>Probable tRNA/rRNA methyltransferase HI0766
MLDIVLYEPEIPQNTGNIIRLCANTGFRLHLIEPLGFTWDDKRLRRSGLDYHEFAEIKRH
KTFEAFLESEKPKRLFALTTKGCPAHSQVKFKLGDYLMFGPETRGIPMSILNEMPMEQKI
RIPMTANSRSMNLSNSVAVTVYEAWRQLGYKGAVNLPEVK

# Drug_Target_16_Reaction:
Not Available

# Drug_Target_16_Signals:
None

# Drug_Target_16_Specific_Function:
Not Available

# Drug_Target_16_SwissProt_ID:
P44868

# Drug_Target_16_SwissProt_Name:
TRML_HAEIN

# Drug_Target_16_Synonyms:
EC 2.1.1.-

# Drug_Target_16_Theoretical_pI:
9.43

# Drug_Target_16_Transmembrane_Regions:
None

# Drug_Target_17_Cellular_Location:
Cytoplasmic

# Drug_Target_17_Chromosome_Location:
Not Available

# Drug_Target_17_Drug_References:
Not Available

# Drug_Target_17_Essentiality:
Non-Essential

# Drug_Target_17_GenAtlas_ID:
Not Available

# Drug_Target_17_GenBank_ID_Gene:
X13778

# Drug_Target_17_GenBank_ID_Protein:
Not Available

# Drug_Target_17_GeneCard_ID:
Not Available

# Drug_Target_17_Gene_Name:
pvuIIM

# Drug_Target_17_Gene_Sequence:
>1011 bp
ATGATGACTTTGAATCTACAGACTATGAGTAGCAATGATATGTTGAATTTTGGAAAAAAA
CCTGCCTACACAACTAGTAATGGGTCTATGTATATAGGTGACTCATTGGAGCTATTAGAA
TCATTCCCAGAAGAAAGTATTAGTCTGGTTATGACTAGTCCTCCCTTCGCATTACAACGA
AAAAAAGAATACGGAAACTTAGAACAGCATGAGTATGTGGATTGGTTTTTGTCATTTGCT
AAAGTGGTTAATAAGAAACTAAAACCGGATGGAAGTTTTGTTGTAGATTTTGGTGGGGCG
TACATGAAAGGCGTTCCAGCAAGAAGTATCTATAACTTTAGAGTTTTGATCAGAATGATA
GACGAAGTGGGTTTTTTTCTTGCTGAAGATTTTTATTGGTTTAACCCATCAAAATTACCA
AGCCCTATAGAATGGGTTAATAAGAGAAAAATAAGAGTTAAAGATGCAGTGAATACAGTA
TGGTGGTTCTCTAAAACAGAGTGGCCTAAGTCTGATATAACGAAAGTTCTAGCTCCATAT
AGCGATAGAATGAAAAAGTTAATTGAAGACCCAGACAAATTCTATACACCAAAAACTAGA
CCATCTGGGCATGATATAGGGAAGTCGTTCTCTAAAGACAATGGAGGTTCAATTCCTCCT
AATTTATTACAAATATCAAACTCAGAATCAAATGGTCAATATTTAGCCAATTGTAAGTTG
ATGGGTATTAAAGCGCATCCCGCTAGATTCCCTGCTAAGTTACCCGAGTTTTTTATTAGA
ATGTTAACTGAGCCAGATGATCTTGTTGTTGATATTTTTGGCGGCTCTAATACTACTGGT
CTAGTCGCAGAAAGAGAATCTCGTAAATGGATCTCGTTTGAGATGAAACCTGAATATGTT
GCGGCATCGGCGTTTCGTTTTTTAGACAATAATATAAGTGAAGAAAAAATAACTGATATT
TATAATCGAATCCTTAATGGTGAGTCTTTGGATTTAAACTCTATTATCTAA

# Drug_Target_17_General_Function:
Involved in DNA binding

# Drug_Target_17_General_References:
2662138	Tao T, Walter J, Brennan KJ, Cotterman MM, Blumenthal RM: Sequence, internal homology and high-level expression of the gene for a DNA-(cytosine N4)-methyltransferase, M.Pvu II. Nucleic Acids Res. 1989 Jun 12;17(11):4161-75.
7607491	Adams GM, Blumenthal RM: Gene pvuIIW: a possible modulator of PvuII endonuclease subunit association. Gene. 1995 May 19;157(1-2):193-9.
9207015	Gong W, O'Gara M, Blumenthal RM, Cheng X: Structure of pvu II DNA-(cytosine N4) methyltransferase, an example of domain permutation and protein fold assignment. Nucleic Acids Res. 1997 Jul 15;25(14):2702-15.

# Drug_Target_17_HGNC_ID:
Not Available

# Drug_Target_17_HPRD_ID:
Not Available

# Drug_Target_17_ID:
4314

# Drug_Target_17_Locus:
Not Available

# Drug_Target_17_Molecular_Weight:
38365

# Drug_Target_17_Name:
Modification methylase PvuII

# Drug_Target_17_Number_of_Residues:
336

# Drug_Target_17_PDB_ID:
1BOO

# Drug_Target_17_Pathway:
Not Available

# Drug_Target_17_Pfam_Domain_Function:
PF01555	N6_N4_Mtase

# Drug_Target_17_Protein_Sequence:
>Modification methylase PvuII
MMTLNLQTMSSNDMLNFGKKPAYTTSNGSMYIGDSLELLESFPDESISLVMTSPPFALQR
KKEYGNLEQHEYVDWFLSFAKVVNKKLKPDGSFVVDFGGAYMKGVPARSIYNFRVLIRMI
DEVGFFLAEDFYWFNPSKLPSPIEWVNKRKIRVKDAVNTVWWFSKTEWPKSDITKVLAPY
SDRMKKLIEDPDKFYTPKTRPSGHDIGKSFSKDNGGSIPPNLLQISNSESNGQYLANCKL
MGIKAHPARFPAKLPEFFIRMLTEPDDLVVDIFGGSNTTGLVAERESRKWISFEMKPEYV
AASAFRFLDNNISEEKITDIYNRILNGESLDLNSII

# Drug_Target_17_Reaction:
Not Available

# Drug_Target_17_Signals:
None

# Drug_Target_17_Specific_Function:
This methylase recognizes the double-stranded sequence CAGCTG, causes specific methylation on C-4 on both strands, and protects the DNA from cleavage by the PvuII endonuclease

# Drug_Target_17_SwissProt_ID:
P11409

# Drug_Target_17_SwissProt_Name:
MTP2_PROVU

# Drug_Target_17_Synonyms:
EC 2.1.1.113
M.PvuII
N-4 cytosine-specific methyltransferase PvuII

# Drug_Target_17_Theoretical_pI:
7.58

# Drug_Target_17_Transmembrane_Regions:
None

# Drug_Target_18_Cellular_Location:
Cytoplasmic

# Drug_Target_18_Chromosome_Location:
Not Available

# Drug_Target_18_Drug_References:
Not Available

# Drug_Target_18_Essentiality:
Non-Essential

# Drug_Target_18_GenAtlas_ID:
Not Available

# Drug_Target_18_GenBank_ID_Gene:
X01416

# Drug_Target_18_GenBank_ID_Protein:
Not Available

# Drug_Target_18_GeneCard_ID:
Not Available

# Drug_Target_18_Gene_Name:
DAM

# Drug_Target_18_Gene_Sequence:
>780 bp
ATGCTAGGAGCTATCGCGTATACAGGTAATAAACAATCATTATTACCTGAACTCAAATCT
CACTTTCCAAAATATAACAGATTCGTGGATTTATTTTGTGGAGGTTTATCAGTGTCTTTG
AATGTTAATGGCCCTGTATTGGCCAATGATATTCAAGAACCAATTATTGAAATGTATAAG
CGTCTTATTAATGTATCATGGGATGACGTTTTAAAAGTAATAAAGCAATACAAACTATCA
AAAACATCAAAAGAAGAGTTTTTGAAATTACGTGAAGATTATAATAAAACTAGAGATCCT
CTTTTACTTTATGTTCTTCATTTTCACGGATTTAGTAATATGATTCGTATAAACGATAAA
GGAAATTTTACTACTCCGTTTGGAAAAAGAACTATAAACAAAAATAGTGAAAAACAATAT
AATCACTTTAAACAAAATTGTGATAAAATAATCTTTAGTTCATTGCATTTTAAAGATGTT
AAAATTTTAGACGGCGATTTTGTATATGTAGATCCTCCGTATCTCATAACAGTTGCTGAT
TATAATAAATTTTGGTCAGAAGATGAAGAAAAAGACCTTTTAAATCTTTTAGATTCTTTA
AATGATAGAGGAATAAAATTTGGGCAGTCGAATGTTTTAGAACACCACGGAAAGGAAAAC
ACTCTTCTTAAAGAATGGTCTAAAAAATATAATGTAAAGCATCTTAATAAAAAATACGTC
TTTAACATATATCATTCCAAAGAAAAGAATGGAACTGATGAAGTATATATTTTTAATTAA

# Drug_Target_18_General_Function:
Involved in DNA binding

# Drug_Target_18_General_References:
12626685	Miller ES, Kutter E, Mosig G, Arisaka F, Kunisawa T, Ruger W: Bacteriophage T4 genome. Microbiol Mol Biol Rev. 2003 Mar;67(1):86-156, table of contents.
12937411	Yang Z, Horton JR, Zhou L, Zhang XJ, Dong A, Zhang X, Schlagman SL, Kossykh V, Hattman S, Cheng X: Structure of the bacteriophage T4 DNA adenine methyltransferase. Nat Struct Biol. 2003 Oct;10(10):849-55. Epub 2003 Aug 24.
2510127	Miner Z, Schlagman SL, Hattman S: Single amino acid changes that alter the DNA sequence specificity of the DNA-[N6-adenine] methyltransferase (Dam) of bacteriophage T4. Nucleic Acids Res. 1989 Oct 25;17(20):8149-57.
6098451	Macdonald PM, Mosig G: Regulation of a new bacteriophage T4 gene, 69, that spans an origin of DNA replication. EMBO J. 1984 Dec 1;3(12):2863-71.

# Drug_Target_18_HGNC_ID:
Not Available

# Drug_Target_18_HPRD_ID:
Not Available

# Drug_Target_18_ID:
4315

# Drug_Target_18_Locus:
Not Available

# Drug_Target_18_Molecular_Weight:
30417

# Drug_Target_18_Name:
DNA adenine methylase

# Drug_Target_18_Number_of_Residues:
259

# Drug_Target_18_PDB_ID:
1Q0T

# Drug_Target_18_Pathway:
Not Available

# Drug_Target_18_Pfam_Domain_Function:
PF02086	MethyltransfD12

# Drug_Target_18_Protein_Sequence:
>DNA adenine methylase
MLGAIAYTGNKQSLLPELKSHFPKYNRFVDLFCGGLSVSLNVNGPVLANDIQEPIIEMYK
RLINVSWDDVLKVIKQYKLSKTSKEEFLKLREDYNKTRDPLLLYVLHFHGFSNMIRINDK
GNFTTPFGKRTINKNSEKQYNHFKQNCDKIIFSSLHFKDVKILDGDFVYVDPPYLITVAD
YNKFWSEDEEKDLLNLLDSLNDRGIKFGQSNVLEHHGKENTLLKEWSKKYNVKHLNKKYV
FNIYHSKEKNGTDEVYIFN

# Drug_Target_18_Reaction:
Not Available

# Drug_Target_18_Signals:
None

# Drug_Target_18_Specific_Function:
This methylase recognizes the double-stranded sequence GATC, causes specific methylation on A-2 on both strands

# Drug_Target_18_SwissProt_ID:
P04392

# Drug_Target_18_SwissProt_Name:
DMA_BPT4

# Drug_Target_18_Synonyms:
Deoxyadenosyl-methyltransferase
EC 2.1.1.72
M.EcoT4Dam

# Drug_Target_18_Theoretical_pI:
9.24

# Drug_Target_18_Transmembrane_Regions:
None

# Drug_Target_19_Cellular_Location:
Not Available

# Drug_Target_19_Chromosome_Location:
Not Available

# Drug_Target_19_Drug_References:
Not Available

# Drug_Target_19_Essentiality:
Non-Essential

# Drug_Target_19_GenAtlas_ID:
Not Available

# Drug_Target_19_GenBank_ID_Gene:
AE000516

# Drug_Target_19_GenBank_ID_Protein:
Not Available

# Drug_Target_19_GeneCard_ID:
Not Available

# Drug_Target_19_Gene_Name:
pcaA

# Drug_Target_19_Gene_Sequence:
>864 bp
TTACTTTTCCAGTGTGAACTGGTCGACGTCGGTGTAACCCTGGCGGAACAGCTTCGCGCA
GCCGGTCAGGTACTTCATGTAGCGGTCGTAGACAGTCTGCGACTGGATCGCGATGGCCTG
ATCTTTGTTGGCCTCGAGCGCTGTGGCCCACATGTCCAGCGTCCTGGCGTAGTGCAGCTG
CAATGACTGGACCGCGGTGACCCGGAAGCCGACCTTCTCGGCGTACTCGTGCACCGTCGG
GATGGACGGCAGCCAGCCACCGGGGAAGATCTCGGCCAGGATGAATTTGGTGAAGTGAAC
CAGTTCGTGGGTCAACGTCAGGCCCTTTTCCCTGCCTTCTTTGAAGGTGGGGCGCACGAT
GGTGTGCAGCAACATCTTGCCGTCGGCCGGCAACGTGCGGTGGGTCACCTCGAAGAAATG
GTGGTAGCGCTGGTGGCCGAAGTGCTCGAACGCGCCGATCGAGACGATGCGGTCGACGGG
CTCGTCAAATTTCTCCCATCCCTCCAGCAACACTCGTCTGGAGCGGGGGGTGTCCATTTG
GTCGAACATTTTCTGGACATGACCGGCCTGGTTCTCCGACAACGTCAGGCCCACGACATT
GACGTCGTATTTCTCGATGGCGCGCCGCATGGTCGCGCCCCAGCCGCAGCCGATGTCCAG
CAACGTCATCCCGGGTTCGAGGTTCAGCTTGCCCAGGGCCAGGTCGATCTTGGCGATCTG
GGCCTCCTGCAGCGTCATGTCGTCGCGTTCGAAGTAGGCACAGCTGTAGGTCTGGGTGGG
GTCCAAGAACAGCCGGAAAAAGTCGTCGGAGAGGTCGTAATGAGCTTGCACGTTTCCAAA
ATGCGGCGTGAGCTGCACGGACAT

# Drug_Target_19_General_Function:
Involved in cyclopropane-fatty-acyl-phospholipid synthase activity

# Drug_Target_19_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_19_HGNC_ID:
Not Available

# Drug_Target_19_HPRD_ID:
Not Available

# Drug_Target_19_ID:
4316

# Drug_Target_19_Locus:
Not Available

# Drug_Target_19_Molecular_Weight:
33028

# Drug_Target_19_Name:
Mycolic acid synthase

# Drug_Target_19_Number_of_Residues:
287

# Drug_Target_19_PDB_ID:
1L1E

# Drug_Target_19_Pathway:
Not Available

# Drug_Target_19_Pfam_Domain_Function:
PF02353	CMAS

# Drug_Target_19_Protein_Sequence:
>Mycolic acid synthase
MSVQLTPHFGNVQAHYDLSDDFFRLFLDPTQTYSCAYFERDDMTLQEAQIAKIDLALGKL
NLEPGMTLLDIGCGWGATMRRAIEKYDVNVVGLTLSENQAGHVQKMFDQMDTPRSRRVLL
EGWEKFDEPVDRIVSIGAFEHFGHQRYHHFFEVTHRTLPADGKMLLHTIVRPTFKEGREK
GLTLTHELVHFTKFILAEIFPGGWLPSIPTVHEYAEKVGFRVTAVQSLQLHYARTLDMWA
TALEANKDQAIAIQSQTVYDRYMKYLTGCAKLFRQGYTDVDQFTLEK

# Drug_Target_19_Reaction:
Not Available

# Drug_Target_19_Signals:
None

# Drug_Target_19_Specific_Function:
Not Available

# Drug_Target_19_SwissProt_ID:
Q7D9R5

# Drug_Target_19_SwissProt_Name:
CMAS3_MYCTU

# Drug_Target_19_Synonyms:
CYCLOPROPANE SYNTHASE
EC 2.-.-.-
MYCOLIC ACID SYNTHASE PCAA

# Drug_Target_19_Theoretical_pI:
6.45

# Drug_Target_19_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
D28567

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
hemK

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_1_General_References:
11805295	Nakahigashi K, Kubo N, Narita S, Shimaoka T, Goto S, Oshima T, Mori H, Maeda M, Wada C, Inokuchi H: HemK, a class of protein methyl transferase with similarity to DNA methyl transferases, methylates polypeptide chain release factors, and hemK knockout induces defects in translational termination. Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1473-8. Epub 2002 Jan 22.
7543480	Strohmaier H, Remler P, Renner W, Hogenauer G: Expression of genes kdsA and kdsB involved in 3-deoxy-D-manno-octulosonic acid metabolism and biosynthesis of enterobacterial lipopolysaccharide is growth phase regulated primarily at the transcriptional level in Escherichia coli K-12. J Bacteriol. 1995 Aug;177(15):4488-500.
7883187	Nakayashiki T, Nishimura K, Inokuchi H: Cloning and sequencing of a previously unidentified gene that is involved in the biosynthesis of heme in Escherichia coli. Gene. 1995 Feb 3;153(1):67-70.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3724

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
30975

# Drug_Target_1_Name:
Protein methyltransferase hemK

# Drug_Target_1_Number_of_Residues:
277

# Drug_Target_1_PDB_ID:
1T43

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF08241	Methyltransf_11

# Drug_Target_1_Protein_Sequence:
>Protein methyltransferase hemK
MEYQHWLREAISQLQASESPRRDAEILLEHVTGRGRTFILAFGETQLTDEQCQQLDALLT
RRRDGEPIAHLTGVREFWSLPLFVSPATLIPRPDTECLVEQALARLPEQPCRILDLGTGT
GAIALALASERPDCEIIAVDRMPDAVSLAQRNAQHLAIKNIHILQSDWFSALAGQQFAMI
VSNPPYIDEQDPHLQQGDVRFEPLTALVAADSGMADIVHIIEQSRNALVSGGFLLLEHGW
QQGEAVRQAFILAGYHDVETCRDYGDNERVTLGRYYQ

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Methylates the translation termination release factor RF1 on 'Gln-235' and RF2 on 'Gln-252'

# Drug_Target_1_SwissProt_ID:
P0ACC1

# Drug_Target_1_SwissProt_Name:
HEMK_ECOLI

# Drug_Target_1_Synonyms:
EC 2.1.1.-
M.EcoKHemKP
Protein-(glutamine-N5MTase hemK
Protein-glutamine N- methyltransferase hemK

# Drug_Target_1_Theoretical_pI:
4.60

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_20_Cellular_Location:
Not Available

# Drug_Target_20_Chromosome_Location:
Not Available

# Drug_Target_20_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_20_Essentiality:
Non-Essential

# Drug_Target_20_GenAtlas_ID:
Not Available

# Drug_Target_20_GenBank_ID_Gene:
Not Available

# Drug_Target_20_GenBank_ID_Protein:
Not Available

# Drug_Target_20_GeneCard_ID:
Not Available

# Drug_Target_20_Gene_Name:
PRMT1

# Drug_Target_20_Gene_Sequence:
Not Available

# Drug_Target_20_General_Function:
Not Available

# Drug_Target_20_General_References:
Not Available

# Drug_Target_20_HGNC_ID:
Not Available

# Drug_Target_20_HPRD_ID:
Not Available

# Drug_Target_20_ID:
7107

# Drug_Target_20_Locus:
Not Available

# Drug_Target_20_Molecular_Weight:
Not Available

# Drug_Target_20_Name:
Protein arginine N-methyltransferase 1

# Drug_Target_20_Number_of_Residues:
0

# Drug_Target_20_PDB_ID:
Not Available

# Drug_Target_20_Pathway:
Not Available

# Drug_Target_20_Pfam_Domain_Function:
Not Available

# Drug_Target_20_Protein_Sequence:
Not Available

# Drug_Target_20_Reaction:
Not Available

# Drug_Target_20_Signals:
Not Available

# Drug_Target_20_Specific_Function:
Not Available

# Drug_Target_20_SwissProt_ID:
Q99873

# Drug_Target_20_SwissProt_Name:
ANM1_HUMAN

# Drug_Target_20_Synonyms:
Not Available

# Drug_Target_20_Theoretical_pI:
Not Available

# Drug_Target_20_Transmembrane_Regions:
Not Available

# Drug_Target_21_Cellular_Location:
Not Available

# Drug_Target_21_Chromosome_Location:
Not Available

# Drug_Target_21_Drug_References:
Not Available

# Drug_Target_21_Essentiality:
Non-Essential

# Drug_Target_21_GenAtlas_ID:
Not Available

# Drug_Target_21_GenBank_ID_Gene:
M64606

# Drug_Target_21_GenBank_ID_Protein:
Not Available

# Drug_Target_21_GeneCard_ID:
Not Available

# Drug_Target_21_Gene_Name:
cysG

# Drug_Target_21_Gene_Sequence:
>1374 bp
GTGGACCATTTGCCTATATTTTGTCAATTACGCGACCGCGACTGTCTGATCGTCGGCGGT
GGCGATGTCGCAGAACGCAAAGCACGGTTACTGCTGGAAGCAGGCGCACGTTTAACGGTC
AATGCGCTAACCTTTATTCCACAGTTCACCGTATGGGCAAATGAAGGCATGTTGACTCTG
GTTGAGGGACCGTTCGACGAAACGCTTCTCGACTCGTGTTGGCTGGCGATCGCGGCCACT
GACGACGATACCGTCAACCAGCGCGTCAGCGACGCGGCGGAGTCACGCCGTATCTTTTGC
AACGTGGTGGATGCGCCGAAAGCCGCCAGCTTTATCATGCCCTCCATTATTGACCGCTCG
CCGCTGATGGTCGCCGTCTCCTCGGGCGGCACCTCCCCGGTGCTGGCGCGTCTGCTGCGC
GAGAAACTGGAATCGCTGCTGCCGCAGCATCTGGGGCAGGTCGCGCGCTATGCCGGGCAA
CTCCGCGCCCGAGTGAAAAAGCAGTTTGCCACGATGGGCGAGCGTCGTCGCTTCTGGGAA
AAATTTTTCGTCAATGACCGGCTGGCGCAGTCGCTGGCGAATGCCGATGAGAAAGCGGTT
AACGCGACAACCGAACGCCTGTTTAGCGAACCGCTGGATCACCGTGGCGAAGTCGTGCTG
GTCGGCGCCGGGCCGGGCGATGCCGGACTGCTGACGCTGAAAGGGTTACAACAAATCCAA
CAGGCGGATATCGTGGTTTACGATCGCCTCGTCTCCGACGACATTATGAACCTGGTACGC
CGCGATGCCGATCGGGTCTTTGTGGGGAAACGCGCGGGTTACCACTGCGTCCCACAGGAG
GAAATCAACCAGATCCTGCTGCGTGAAGCGCAAAAAGGTAAACGCGTGGTACGCCTGAAA
GGCGGCGATCCCTTTATCTTTGGTCGCGGCGGCGAAGAGCTGGAAACGCTGTGTCATGCC
GGTATTCCTTTCTCGGTAGTGCCGGGGATTACCGCGGCTTCCGGCTGCTCCGCCTACTCC
GGTATTCCGCTAACTCATCGCGATTACGCCCAGAGCGTACGTCTGGTCACGGGTCACCTG
AAAACCGGCGGCGAGCTGGACTGGGAAAACCTGGCGGCAGAAAAACAGACGCTGGTGTTC
TACATGGGGCTGAATCAGGCAGCGACTATCCAGGAAAAACTGATCGCATTCGGTATGCAG
GCCGATATGCCGGTTGCGCTGGTAGAAAACGGTACCTCCGTGAAGCAACGCGTCGTCCAC
GGTGTGCTGACGCAGCTCGGTGAATTAGCGCAACAGGTTGAAAGCCCGGCGCTGATTATC
GTTGGTCGCGTGGTAGCCTTACGCGATAAATTAAATTGGTTCTCTAATCATTAA

# Drug_Target_21_General_Function:
Involved in methyltransferase activity

# Drug_Target_21_General_References:
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.
1987123	Wu JY, Siegel LM, Kredich NM: High-level expression of Escherichia coli NADPH-sulfite reductase: requirement for a cloned cysG plasmid to overcome limiting siroheme cofactor. J Bacteriol. 1991 Jan;173(1):325-33.

# Drug_Target_21_HGNC_ID:
Not Available

# Drug_Target_21_HPRD_ID:
Not Available

# Drug_Target_21_ID:
4318

# Drug_Target_21_Locus:
Not Available

# Drug_Target_21_Molecular_Weight:
50147

# Drug_Target_21_Name:
Siroheme synthase

# Drug_Target_21_Number_of_Residues:
457

# Drug_Target_21_PDB_ID:
1PJT

# Drug_Target_21_Pathway:
Not Available

# Drug_Target_21_Pfam_Domain_Function:
PF00590	TP_methylase

# Drug_Target_21_Protein_Sequence:
>Siroheme synthase
MDHLPIFCQLRDRDCLIVGGGDVAERKARLLLEAGARLTVNALTFIPQFTVWANEGMLTL
VEGPFDETLLDSCWLAIAATDDDTVNQRVSDAAESRRIFCNVVDAPKAASFIMPSIIDRS
PLMVAVSSGGTSPVLARLLREKLESLLPQHLGQVARYAGQLRARVKKQFATMGERRRFWE
KFFVNDRLAQSLANADEKAVNATTERLFSEPLDHRGEVVLVGAGPGDAGLLTLKGLQQIQ
QADIVVYDRLVSDDIMNLVRRDADRVFVGKRAGYHCVPQEEINQILLREAQKGKRVVRLK
GGDPFIFGRGGEELETLCHAGIPFSVVPGITAASGCSAYSGIPLTHRDYAQSVRLVTGHL
KTGGELDWENLAAEKQTLVFYMGLNQAATIQEKLIAFGMQADMPVALVENGTSVKQRVVH
GVLTQLGELAQQVESPALIIVGRVVALRDKLNWFSNH

# Drug_Target_21_Reaction:
Not Available

# Drug_Target_21_Signals:
None

# Drug_Target_21_Specific_Function:
Multifunctional enzyme that catalyze the SAM-dependent methylation of uroporphyrinogen III at position C-2 and C-7 to form precorrin-2 and then position C-12 or C-18 to form trimethylpyrrocorphin 2. It also catalyzes the conversion of precorrin-2 into siroheme. This reaction consist of the NAD- dependent oxidation of precorrin-2 into sirohydrochlorin and its subsequent ferrochelation into siroheme

# Drug_Target_21_SwissProt_ID:
P25924

# Drug_Target_21_SwissProt_Name:
CYSG_SALTY

# Drug_Target_21_Synonyms:
Not Available

# Drug_Target_21_Theoretical_pI:
6.79

# Drug_Target_21_Transmembrane_Regions:
None

# Drug_Target_22_Cellular_Location:
Cytoplasmic

# Drug_Target_22_Chromosome_Location:
Not Available

# Drug_Target_22_Drug_References:
Not Available

# Drug_Target_22_Essentiality:
Non-Essential

# Drug_Target_22_GenAtlas_ID:
Not Available

# Drug_Target_22_GenBank_ID_Gene:
J02677

# Drug_Target_22_GenBank_ID_Protein:
Not Available

# Drug_Target_22_GeneCard_ID:
Not Available

# Drug_Target_22_Gene_Name:
hhaIM

# Drug_Target_22_Gene_Sequence:
>984 bp
ATGATTGAAATAAAAGATAAACAGCTCACAGGATTACGCTTTATTGACCTTTTTGCAGGA
TTAGGTGGCTTTAGACTTGCTTTAGAATCTTGCGGTGCTGAGTGCGTTTATTCTAATGAA
TGGGATAAATATGCACAAGAAGTATATGAGATGAATTTTGGTGAAAAGCCTGAGGGCGAC
ATTACCCAAGTAAATGAGAAAACCATTCCTGATCACGACATTTTATGTGCAGGGTTTCCG
TGCCAAGCGTTTTCTATTAGTGGAAAACAAAAAGGATTCGAGGACAGCAGAGGTACGCTC
TTTTTTGATATTGCACGTATTGTCCGTGAAAAAAAACCTAAAGTGGTTTTTATGGAAAAT
GTGAAAAATTTTGCATCGCATGATAATGGAAATACGTTAGAAGTTGTAAAAAATACAATG
AATGAATTGGACTATTCTTTTCATGCTAAAGTATTAAATGCTTTAGATTATGGGATTCCA
CAGAAAAGGGAACGTATCTATATGATTTGTTTTCGCAATGATCTCAATATTCAAAATTTC
CAATTTCCAAAACCTTTTGAGCTTAATACTTTTGTGAAAGATTTGTTATTACCTGATAGC
GAGGTGGAACACTTAGTTATTGATAGAAAAGATTTGGTAATGACAAACCAAGAAATTGAG
CAAACAACCCCCAAAACAGTTCGACTTGGTATTGTAGGAAAAGGTGGGCAAGGAGAACGA
ATTTATAGCACAAGAGGCATTGCAATTACCTTATCTGCTTATGGTGGCGGCATTTTCGCT
AAGACAGGGGGATATTTAGTAAACGGGAAGACACGGAAATTACACCCTAGAGAGTGTGCT
AGAGTAATGGGCTACCCAGATAGTTATAAAGTCCACCCGTCAACCAGCCAAGCATATAAA
CAATTTGGTAACTCAGTTGTTATCAATGTACTTCAATATATTGCTTATAACATTGGTTCA
TCATTAAATTTCAAACCATATTAA

# Drug_Target_22_General_Function:
Involved in DNA binding

# Drug_Target_22_General_References:
10080885	O'Gara M, Zhang X, Roberts RJ, Cheng X: Structure of a binary complex of HhaI methyltransferase with S-adenosyl-L-methionine formed in the presence of a short non-specific DNA oligonucleotide. J Mol Biol. 1999 Mar 26;287(2):201-9.
3549710	Caserta M, Zacharias W, Nwankwo D, Wilson GG, Wells RD: Cloning, sequencing, in vivo promoter mapping, and expression in Escherichia coli of the gene for the HhaI methyltransferase. J Biol Chem. 1987 Apr 5;262(10):4770-7.
7899082	Mi S, Alonso D, Roberts RJ: Functional analysis of Gln-237 mutants of HhaI methyltransferase. Nucleic Acids Res. 1995 Feb 25;23(4):620-7.
8293469	Klimasauskas S, Kumar S, Roberts RJ, Cheng X: HhaI methyltransferase flips its target base out of the DNA helix. Cell. 1994 Jan 28;76(2):357-69.
8343957	Cheng X, Kumar S, Posfai J, Pflugrath JW, Roberts RJ: Crystal structure of the HhaI DNA methyltransferase complexed with S-adenosyl-L-methionine. Cell. 1993 Jul 30;74(2):299-307.
8506140	Mi S, Roberts RJ: The DNA binding affinity of HhaI methylase is increased by a single amino acid substitution in the catalytic center. Nucleic Acids Res. 1993 May 25;21(10):2459-64.
9207024	Kumar S, Horton JR, Jones GD, Walker RT, Roberts RJ, Cheng X: DNA containing 4'-thio-2'-deoxycytidine inhibits methylation by HhaI methyltransferase. Nucleic Acids Res. 1997 Jul 15;25(14):2773-83.
9783745	O'Gara M, Horton JR, Roberts RJ, Cheng X: Structures of HhaI methyltransferase complexed with substrates containing mismatches at the target base. Nat Struct Biol. 1998 Oct;5(10):872-7.

# Drug_Target_22_HGNC_ID:
Not Available

# Drug_Target_22_HPRD_ID:
Not Available

# Drug_Target_22_ID:
4323

# Drug_Target_22_Locus:
Not Available

# Drug_Target_22_Molecular_Weight:
36997

# Drug_Target_22_Name:
Modification methylase HhaI

# Drug_Target_22_Number_of_Residues:
327

# Drug_Target_22_PDB_ID:
1SKM

# Drug_Target_22_Pathway:
Not Available

# Drug_Target_22_Pfam_Domain_Function:
PF00145	DNA_methylase

# Drug_Target_22_Protein_Sequence:
>Modification methylase HhaI
MIEIKDKQLTGLRFIDLFAGLGGFRLALESCGAECVYSNEWDKYAQEVYEMNFGEKPEGD
ITQVNEKTIPDHDILCAGFPCQAFSISGKQKGFEDSRGTLFFDIARIVREKKPKVVFMEN
VKNFASHDNGNTLEVVKNTMNELDYSFHAKVLNALDYGIPQKRERIYMICFRNDLNIQNF
QFPKPFELNTFVKDLLLPDSEVEHLVIDRKDLVMTNQEIEQTTPKTVRLGIVGKGGQGER
IYSTRGIAITLSAYGGGIFAKTGGYLVNGKTRKLHPRECARVMGYPDSYKVHPSTSQAYK
QFGNSVVINVLQYIAYNIGSSLNFKPY

# Drug_Target_22_Reaction:
Not Available

# Drug_Target_22_Signals:
None

# Drug_Target_22_Specific_Function:
This methylase recognizes the double-stranded sequence GCGC, causes specific methylation on C-2 on both strands, and protects the DNA from cleavage by the HhaI endonuclease

# Drug_Target_22_SwissProt_ID:
P05102

# Drug_Target_22_SwissProt_Name:
MTH1_HAEPH

# Drug_Target_22_Synonyms:
Cytosine-specific methyltransferase HhaI
EC 2.1.1.37
M.HhaI

# Drug_Target_22_Theoretical_pI:
7.82

# Drug_Target_22_Transmembrane_Regions:
None

# Drug_Target_23_Cellular_Location:
Nucleus (Probable)

# Drug_Target_23_Chromosome_Location:
Not Available

# Drug_Target_23_Drug_References:
Not Available

# Drug_Target_23_Essentiality:
Non-Essential

# Drug_Target_23_GenAtlas_ID:
SETD7

# Drug_Target_23_GenBank_ID_Gene:
AF448510

# Drug_Target_23_GenBank_ID_Protein:
Not Available

# Drug_Target_23_GeneCard_ID:
Not Available

# Drug_Target_23_Gene_Name:
SETD7

# Drug_Target_23_Gene_Sequence:
>1101 bp
ATGGATAGCGACGACGAGATGGTGGAGGAGGCGGTGGAAGGGCACCTGGACGATGACGGA
TTACCGCACGGGTTCTGCACAGTCACCTACTCCTCCACAGACAGATTTGAGGGGAACTTT
GTTCACGGAGAAAAGAACGGACGGGGGAAGTTCTTCTTCTTTGATGGCAGCACCCTGGAG
GGGTATTATGTGGATGATGCCTTGCAGGGCCAGGGAGTTTACACTTACGAAGATGGGGGA
GTTCTCCAGGGCACGTATGTAGACGGAGAGCTGAACGGTCCAGCCCAGGAATATGACACA
GATGGGAGACTGATCTTCAAGGGGCAGTATAAAGATAACATTCGTCATGGAGTGTGCTGG
ATATATTACCCAGATGGAGGAAGCCTTGTAGGAGAAGTAAATGAAGATGGGGAGATGACT
GGAGAGAAGATAGCCTATGTGTACCCTGATGAGAGGACCGCACTTTATGGGAAATTTATT
GATGGAGAGATGATAGAAGGCAAACTGGCTACCCTTATGTCCACTGAAGAAGGGAGGCCT
CACTTTGAACTGATGCCTGGAAATTCAGTGTACCACTTTGATAAGTCGACTTCATCTTGC
ATTTCTACCAATGCTCTTCTTCCAGATCCTTATGAATCAGAAAGGGTTTATGTTGCTGAA
TCTCTTATTTCCAGTGCTGGAGAAGGACTTTTTTCAAAGGTAGCTGTGGGACCTAATACT
GTTATGTCTTTTTATAATGGAGTTCGAATTACACACCAAGAGGTTGACAGCAGGGACTGG
GCCCTTAATGGGAACACCCTCTCCCTTGATGAAGAAACGGTCATTGATGTGCCTGAGCCC
TATAACCACGTATCCAAGTACTGTGCCTCCTTGGGACACAAGGCAAATCACTCCTTCACT
CCAAACTGCATCTACGATATGTTTGTCCACCCCCGTTTTGGGCCCATCAAATGCATCCGC
ACCCTGAGAGCAGTGGAGGCCGATGAAGAGCTCACCGTTGCCTATGGCTATGACCACAGC
CCCCCCGGGAAGAGTGGGCCTGAAGCCCCTGAGTGGTACCAGGTGGAGCTGAAGGCCTTC
CAGGCCACCCAGCAAAAGTGA

# Drug_Target_23_General_Function:
Not Available

# Drug_Target_23_General_References:
11214970	Nagase T, Kikuno R, Hattori A, Kondo Y, Okumura K, Ohara O: Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 2000 Dec 31;7(6):347-55.
11779497	Wang H, Cao R, Xia L, Erdjument-Bromage H, Borchers C, Tempst P, Zhang Y: Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Mol Cell. 2001 Dec;8(6):1207-17.
11850410	Nishioka K, Chuikov S, Sarma K, Erdjument-Bromage H, Allis CD, Tempst P, Reinberg D: Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev. 2002 Feb 15;16(4):479-89.
12372304	Wilson JR, Jing C, Walker PA, Martin SR, Howell SA, Blackburn GM, Gamblin SJ, Xiao B: Crystal structure and functional analysis of the histone methyltransferase SET7/9. Cell. 2002 Oct 4;111(1):105-15.
12389038	Jacobs SA, Harp JM, Devarakonda S, Kim Y, Rastinejad F, Khorasanizadeh S: The active site of the SET domain is constructed on a knot. Nat Struct Biol. 2002 Nov;9(11):833-8.
12514135	Kwon T, Chang JH, Kwak E, Lee CW, Joachimiak A, Kim YC, Lee J, Cho Y: Mechanism of histone lysine methyl transfer revealed by the structure of SET7/9-AdoMet. EMBO J. 2003 Jan 15;22(2):292-303.
12540855	Xiao B, Jing C, Wilson JR, Walker PA, Vasisht N, Kelly G, Howell S, Taylor IA, Blackburn GM, Gamblin SJ: Structure and catalytic mechanism of the human histone methyltransferase SET7/9. Nature. 2003 Feb 6;421(6923):652-6. Epub 2003 Jan 22.

# Drug_Target_23_HGNC_ID:
HGNC:30412

# Drug_Target_23_HPRD_ID:
Not Available

# Drug_Target_23_ID:
4324

# Drug_Target_23_Locus:
4q28

# Drug_Target_23_Molecular_Weight:
40721

# Drug_Target_23_Name:
Histone-lysine N-methyltransferase, H3 lysine-4 specific SET7

# Drug_Target_23_Number_of_Residues:
366

# Drug_Target_23_PDB_ID:
1N6C

# Drug_Target_23_Pathway:
Not Available

# Drug_Target_23_Pfam_Domain_Function:
PF00856	SET
PF02493	MORN

# Drug_Target_23_Protein_Sequence:
>Histone-lysine N-methyltransferase, H3 lysine-4 specific SET7
MDSDDEMVEEAVEGHLDDDGLPHGFCTVTYSSTDRFEGNFVHGEKNGRGKFFFFDGSTLE
GYYVDDALQGQGVYTYEDGGVLQGTYVDGELNGPAQEYDTDGRLIFKGQYKDNIRHGVCW
IYYPDGGSLVGEVNEDGEMTGEKIAYVYPDERTALYGKFIDGEMIEGKLATLMSTEEGRP
HFELMPGNSVYHFDKSTSSCISTNALLPDPYESERVYVAESLISSAGEGLFSKVAVGPNT
VMSFYNGVRITHQEVDSRDWALNGNTLSLDEETVIDVPEPYNHVSKYCASLGHKANHSFT
PNCIYDMFVHPRFGPIKCIRTLRAVEADEELTVAYGYDHSPPGKSGPEAPEWYQVELKAF
QATQQK

# Drug_Target_23_Reaction:
Not Available

# Drug_Target_23_Signals:
None

# Drug_Target_23_Specific_Function:
Histone methyltransferase. Methylates 'Lys-4' of histone H3, a specific tag for epigenetic transcriptional activation

# Drug_Target_23_SwissProt_ID:
Q8WTS6

# Drug_Target_23_SwissProt_Name:
SETD7_HUMAN

# Drug_Target_23_Synonyms:
EC 2.1.1.43
H3-K4-HMTase
Histone H3-K4 methyltransferase
SET domain-containing protein 7
SET7/9
Set9

# Drug_Target_23_Theoretical_pI:
4.25

# Drug_Target_23_Transmembrane_Regions:
None

# Drug_Target_24_Cellular_Location:
Cytoplasm (Potential)

# Drug_Target_24_Chromosome_Location:
Not Available

# Drug_Target_24_Drug_References:
Not Available

# Drug_Target_24_Essentiality:
Non-Essential

# Drug_Target_24_GenAtlas_ID:
Not Available

# Drug_Target_24_GenBank_ID_Gene:
L42023

# Drug_Target_24_GenBank_ID_Protein:
Not Available

# Drug_Target_24_GeneCard_ID:
Not Available

# Drug_Target_24_Gene_Name:
trmD

# Drug_Target_24_Gene_Sequence:
>741 bp
CTAACTGTTATGCTCGGCTTGCGCCTCTTTTAACAGCTTACGTTGTTCGTCAGTCAGAGC
TAGGCCTTCTAAGAGCTCAGGGCGTCGGAGCCACGTTCTCTGTAGCGATTGTTTTAATCG
CCATTTCCGAATTTCTTCGTGATGTCCCGACATCAGCACGGGTGGTACAGTTAATCCTTC
TAACACTTCTGGTCTAGTGTAATGCGGGCAATCTAATAAACCATCTGCAAAAGAATCTTC
TTCTGCCGAGGCTTGTTTGCCTAATACACCGGGAATAAAACGTGCAACAGCATCAATTAA
TGTCATTGCCGGCAATTCCCCACCGGTCAGAACGTAATCGCCGATTGACCATTCTTCATC
AATTTCAGTTTGAATCAACCGTTCATCAATCCCTTCGTAACGTCCACATACTAAAATCAA
TTTCTGATTTTGAGCAAGCTCGGTTACGCCGCCTTGATCGAGTTTACGTCCTTGTGGCGA
AAGGTAAATCACCTTTGCGCCTTCTCCTGCCGCAGCTTTTGCAGTATGAATCGCATCCCG
TAAAGGTTGCACCATCATTAGCATTCCTGGGCCACCACCATAAGGGCGATCGTCCACGGT
TTTATGCTTGTCGAATGTAAAATCTCTTGGATTCCAACATTCAACTTTCAGAAGATTATG
TTTTACGGCTCTACCTGTAACCCCAAATTCCGTAATTGCTTTAAACATTTCGGGGAATAA
TGAAATTACCCCTATCCACAT

# Drug_Target_24_General_Function:
Involved in RNA binding

# Drug_Target_24_General_References:
7542800	Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM, et al.: Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science. 1995 Jul 28;269(5223):496-512.

# Drug_Target_24_HGNC_ID:
Not Available

# Drug_Target_24_HPRD_ID:
Not Available

# Drug_Target_24_ID:
4325

# Drug_Target_24_Locus:
Not Available

# Drug_Target_24_Molecular_Weight:
27543

# Drug_Target_24_Name:
tRNA

# Drug_Target_24_Number_of_Residues:
246

# Drug_Target_24_PDB_ID:
1UAM

# Drug_Target_24_Pathway:
Not Available

# Drug_Target_24_Pfam_Domain_Function:
PF01746	tRNA_m1G_MT

# Drug_Target_24_Protein_Sequence:
>tRNA
MWIGVISLFPEMFKAITEFGVTGRAVKHNLLKVECWNPRDFTFDKHKTVDDRPYGGGPGM
LMMVQPLRDAIHTAKAAAGEGAKVIYLSPQGRKLDQGGVTELAQNQKLILVCGRYEGIDE
RLIQTEIDEEWSIGDYVLTGGELPAMTLIDAVARFIPGVLGKQASAEEDSFADGLLDCPH
YTRPEVLEGLTVPPVLMSGHHEEIRKWRLKQSLQRTWLRRPELLEGLALTDEQRKLLKEA
QAEHNS

# Drug_Target_24_Reaction:
Not Available

# Drug_Target_24_Signals:
None

# Drug_Target_24_Specific_Function:
Specifically methylates guanosine-37 in various tRNAs (By similarity)

# Drug_Target_24_SwissProt_ID:
P43912

# Drug_Target_24_SwissProt_Name:
TRMD_HAEIN

# Drug_Target_24_Synonyms:
EC 2.1.1.31
M1G- methyltransferase
guanine-N(1)-)-methyltransferase
tRNA [GM37] methyltransferase

# Drug_Target_24_Theoretical_pI:
5.65

# Drug_Target_24_Transmembrane_Regions:
None

# Drug_Target_25_Cellular_Location:
Not Available

# Drug_Target_25_Chromosome_Location:
Not Available

# Drug_Target_25_Drug_References:
Not Available

# Drug_Target_25_Essentiality:
Non-Essential

# Drug_Target_25_GenAtlas_ID:
Not Available

# Drug_Target_25_GenBank_ID_Gene:
BX842574

# Drug_Target_25_GenBank_ID_Protein:
Not Available

# Drug_Target_25_GeneCard_ID:
Not Available

# Drug_Target_25_Gene_Name:
mmaA2

# Drug_Target_25_Gene_Sequence:
>864 bp
CTACTTCGCCAGCGTGAACTGGTTGACGTCGATGTAGCCGACCCGGAACAGCTTGGCGCA
GCCGGTCAGGTATTTCATGTACCGCTCGTAGACCTCTTCGGACTGGATCGCGATGGCCTC
GCTTTTGTGTTCCTGCAGCGCCTCGGCCCACAGGTCGAGGGTCCTGGCGTAATGCGGCTG
CAGCGACTGGCGGCGAGTCAGCGTGAAACCCGTCTTCGCCGACTGTTCCTCAACCATTTC
AATCGTCGGAGGTTGGCCCCCCGGGAAGATTTCGGTCGCGATGAACTTGAGAAAGCGGGC
CAGCCACAACGTGAGCGGCAAGCCGTGGTCGACCATCTGCTGCCTGGTCAGGCCGGTGAT
CGTGTGCAGCAGCAACACGCCATCGGGCGGCAGGATTTTGTGGGCCCGGGCGAAGAAGTC
GGCGTGACGATCGTGGCCGAAGTGCTCGAACGCGCCGATCGACACGATGCGGTCGACGGG
CTCGTTGAACTGCTCCCATCCCGCCAGCAACACTCGCCTGTCGCGCGGGGTGTCCATCTC
GTCGAACGACTTCTGCACATGGGCGGCCTGGTTCTTCGACAATGTCAGGCCGACGACGTT
GACGTCATACTGCGCGATCGCGCGCCGCATGGTGGCGCCCCAGCCGCAACCGATATCGAG
CAGCGTCATGCCGGGCTGCAGACCTAGCTTGCCCAGCGCCAGGTCGATCTTGGCGATCTG
GGCCTCTTCCAGCGTCATGTCCTCGCGTTCGAAATGCGCGCAGCTGTAGGTCTGGGTCGG
ATCCAGGAACAGCCGGAAGAAGTCGTCGGACAGGTCGTAGTGTGCCTGCACGTCCTCGAA
GTGCGGCGTTAGGTCGTTGACCAT

# Drug_Target_25_General_Function:
Involved in cyclopropane-fatty-acyl-phospholipid synthase activity

# Drug_Target_25_General_References:
12368430	Camus JC, Pryor MJ, Medigue C, Cole ST: Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv. Microbiology. 2002 Oct;148(Pt 10):2967-73.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_25_HGNC_ID:
Not Available

# Drug_Target_25_HPRD_ID:
Not Available

# Drug_Target_25_ID:
4302

# Drug_Target_25_Locus:
Not Available

# Drug_Target_25_Molecular_Weight:
32725

# Drug_Target_25_Name:
METHOXY MYCOLIC ACID SYNTHASE 2 MMAA2

# Drug_Target_25_Number_of_Residues:
287

# Drug_Target_25_PDB_ID:
1TPY

# Drug_Target_25_Pathway:
Not Available

# Drug_Target_25_Pfam_Domain_Function:
PF02353	CMAS

# Drug_Target_25_Protein_Sequence:
>METHOXY MYCOLIC ACID SYNTHASE 2 MMAA2
MVNDLTPHFEDVQAHYDLSDDFFRLFLDPTQTYSCAHFEREDMTLEEAQIAKIDLALGKL
GLQPGMTLLDIGCGWGATMRRAIAQYDVNVVGLTLSKNQAAHVQKSFDEMDTPRDRRVLL
AGWEQFNEPVDRIVSIGAFEHFGHDRHADFFARAHKILPPDGVLLLHTITGLTRQQMVDH
GLPLTLWLARFLKFIATEIFPGGQPPTIEMVEEQSAKTGFTLTRRQSLQPHYARTLDLWA
EALQEHKSEAIAIQSEEVYERYMKYLTGCAKLFRVGYIDVNQFTLAK

# Drug_Target_25_Reaction:
Not Available

# Drug_Target_25_Signals:
None

# Drug_Target_25_Specific_Function:
Not Available

# Drug_Target_25_SwissProt_ID:
Q79FX6

# Drug_Target_25_SwissProt_Name:
MMAA2_MYCTU

# Drug_Target_25_Synonyms:
EC 2.1.1.-
HYDROXY MYCOLIC ACID SYNTHASE
METHYL MYCOLIC ACID SYNTHASE 2
MMA2

# Drug_Target_25_Theoretical_pI:
5.73

# Drug_Target_25_Transmembrane_Regions:
None

# Drug_Target_26_Cellular_Location:
Not Available

# Drug_Target_26_Chromosome_Location:
Not Available

# Drug_Target_26_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_26_Essentiality:
Non-Essential

# Drug_Target_26_GenAtlas_ID:
Not Available

# Drug_Target_26_GenBank_ID_Gene:
Not Available

# Drug_Target_26_GenBank_ID_Protein:
Not Available

# Drug_Target_26_GeneCard_ID:
Not Available

# Drug_Target_26_Gene_Name:
DPH5

# Drug_Target_26_Gene_Sequence:
Not Available

# Drug_Target_26_General_Function:
Not Available

# Drug_Target_26_General_References:
Not Available

# Drug_Target_26_HGNC_ID:
Not Available

# Drug_Target_26_HPRD_ID:
Not Available

# Drug_Target_26_ID:
6951

# Drug_Target_26_Locus:
Not Available

# Drug_Target_26_Molecular_Weight:
Not Available

# Drug_Target_26_Name:
Diphthine synthase

# Drug_Target_26_Number_of_Residues:
0

# Drug_Target_26_PDB_ID:
Not Available

# Drug_Target_26_Pathway:
Not Available

# Drug_Target_26_Pfam_Domain_Function:
Not Available

# Drug_Target_26_Protein_Sequence:
Not Available

# Drug_Target_26_Reaction:
Not Available

# Drug_Target_26_Signals:
Not Available

# Drug_Target_26_Specific_Function:
Not Available

# Drug_Target_26_SwissProt_ID:
Q9H2P9

# Drug_Target_26_SwissProt_Name:
DPH5_HUMAN

# Drug_Target_26_Synonyms:
Not Available

# Drug_Target_26_Theoretical_pI:
Not Available

# Drug_Target_26_Transmembrane_Regions:
Not Available

# Drug_Target_27_Cellular_Location:
Not Available

# Drug_Target_27_Chromosome_Location:
Not Available

# Drug_Target_27_Drug_References:
Not Available

# Drug_Target_27_Essentiality:
Non-Essential

# Drug_Target_27_GenAtlas_ID:
Not Available

# Drug_Target_27_GenBank_ID_Gene:
U10405

# Drug_Target_27_GenBank_ID_Protein:
Not Available

# Drug_Target_27_GeneCard_ID:
Not Available

# Drug_Target_27_Gene_Name:
rdmB

# Drug_Target_27_Gene_Sequence:
>1125 bp
GTGAGCTCTTCCTCACCCGGGGAACCCCTGGAACCGACCGACCAGGACCTCGACGTACTC
CTGAAGAACCTCGGCAATCTGGTGACCCCGATGGCCCTGAGGGTCGCCGCGACACTCCGC
CTGGTCGATCACCTGCTGGCCGGAGCCGACACCCTCGCCGGCCTCGCCGACCGTACGGAC
ACCCATCCCCAGGCGCTCTCCCGCCTGGTCCGGCACCTGACCGTCGTCGGCGTCCTGGAG
GGCGGCGAGAAGCAGGGCCGGCCGCTGCGCCCCACCCGGCTCGGGATGCTCCTCGCCGAC
GGCCACCCGGCCCAGCAGCGGGCCTGGCTGGACCTGAACGGGGCCGTCTCCCACGCCGAC
CTGGCCTTCACCGGGCTCCTCGACGTGGTCCGCACCGGCCGCCCCGCCTACGCCGGGCGG
TACGGGCGGCCCTTCTGGGAGGACCTCTCGGCGGACGTGGCGCTGGCCGACTCCTTCGAC
GCGCTCATGTCCTGCGACGAGGACCTGGCCTACGAGGCCCCGGCCGACGCGTACGACTGG
TCGGCGGTCCGGCACGTCCTCGACGTGGGCGGCGGCAACGGCGGCATGCTCGCGGCGATC
GCCCTGCGGGCCCCGCACCTGCGCGGCACCCTGGTCGAACTGGCCGGTCCCGCCGAGCGC
GCCCGGCGCAGGTTCGCGGACGCCGGTCTGGCCGACCGGGTCACGGTGGCGGAGGGCGAC
TTCTTCAAGCCGCTGCCCGTCACCGCCGACGTCGTCCTGCTGTCGTTCGTCCTGCTCAAC
TGGTCCGACGAGGACGCGCTGACGATCCTGCGCGGCTGCGTCAGGGCGCTGGAGCCGGGA
GGCAGGCTCCTGGTCCTCGACCGTGCCGATGTCGAGGGGGACGGCGCCGACCGGTTCTTC
AGCACGCTGCTCGACCTGCGGATGCTGACGTTCATGGGCGGACGGGTGCGCACCCGGGAC
GAGGTCGTGGACCTGGCCGGATCGGCCGGACTCGCCCTGGCCTCGGAGCGCACGAGCGGC
TCCACGACCCTCCCGTTCGACTTCTCGATCCTCGAGTTCACGGCCGTCTCCGAGGAAGCG
GCCCCGGCCGCCCAGGCCTCCGAAGCCCTCCCAGCACAGGAGTAG

# Drug_Target_27_General_Function:
Involved in O-methyltransferase activity

# Drug_Target_27_General_References:
7751313	Niemi J, Mantsala P: Nucleotide sequences and expression of genes from Streptomyces purpurascens that cause the production of new anthracyclines in Streptomyces galilaeus. J Bacteriol. 1995 May;177(10):2942-5.
8081500	Niemi J, Ylihonko K, Hakala J, Parssinen R, Kopio A, Mantsala P: Hybrid anthracycline antibiotics: production of new anthracyclines by cloned genes from Streptomyces purpurascens in Streptomyces galilaeus. Microbiology. 1994 Jun;140 ( Pt 6):1351-8.

# Drug_Target_27_HGNC_ID:
Not Available

# Drug_Target_27_HPRD_ID:
Not Available

# Drug_Target_27_ID:
4327

# Drug_Target_27_Locus:
Not Available

# Drug_Target_27_Molecular_Weight:
39797

# Drug_Target_27_Name:
RdmB

# Drug_Target_27_Number_of_Residues:
374

# Drug_Target_27_PDB_ID:
1R00

# Drug_Target_27_Pathway:
Not Available

# Drug_Target_27_Pfam_Domain_Function:
PF00891	Methyltransf_2

# Drug_Target_27_Protein_Sequence:
>RdmB
MSSSSPGEPLEPTDQDLDVLLKNLGNLVTPMALRVAATLRLVDHLLAGADTLAGLADRTD
THPQALSRLVRHLTVVGVLEGGEKQGRPLRPTRLGMLLADGHPAQQRAWLDLNGAVSHAD
LAFTGLLDVVRTGRPAYAGRYGRPFWEDLSADVALADSFDALMSCDEDLAYEAPADAYDW
SAVRHVLDVGGGNGGMLAAIALRAPHLRGTLVELAGPAERARRRFADAGLADRVTVAEGD
FFKPLPVTADVVLLSFVLLNWSDEDALTILRGCVRALEPGGRLLVLDRADVEGDGADRFF
STLLDLRMLTFMGGRVRTRDEVVDLAGSAGLALASERTSGSTTLPFDFSILEFTAVSEEA
APAAQASEALPAQE

# Drug_Target_27_Reaction:
Not Available

# Drug_Target_27_Signals:
None

# Drug_Target_27_Specific_Function:
Not Available

# Drug_Target_27_SwissProt_ID:
Q54527

# Drug_Target_27_SwissProt_Name:
Q54527_9ACTO

# Drug_Target_27_Synonyms:
Not Available

# Drug_Target_27_Theoretical_pI:
4.48

# Drug_Target_27_Transmembrane_Regions:
None

# Drug_Target_28_Cellular_Location:
Cytoplasm (Potential)

# Drug_Target_28_Chromosome_Location:
Not Available

# Drug_Target_28_Drug_References:
Not Available

# Drug_Target_28_Essentiality:
Non-Essential

# Drug_Target_28_GenAtlas_ID:
Not Available

# Drug_Target_28_GenBank_ID_Gene:
AE005674

# Drug_Target_28_GenBank_ID_Protein:
Not Available

# Drug_Target_28_GeneCard_ID:
Not Available

# Drug_Target_28_Gene_Name:
trmD

# Drug_Target_28_Gene_Sequence:
>768 bp
TTACGCCATCCCATCATGTTTATGTTGCTGTTGTGCGTGTTCCGTTTTGAACTCCGCCAG
CAACCTTGCTTGCTCTTCAGTCAGAGCCAGGTTTTCCAGAAGTTCAGGTCTTCTAAGCCA
GGTACGGCCCAGCGACTGTTTCAAACGCCAGCGACGTATCTCGGCATGGTTGCCCGACAG
TAACACTGGCGGAACTTCCATCCCTTCTAACACCTCAGGCCGCGTATAGTGCGGGCAATC
CAGCAATCCTTCAGCAAAGGAATCTTCCGTTGCCGAGGCTTCATGTCCCAGTACTCCCGG
AATAAACCGGGAAACGGAGTCAATCAGCGTCATTGCTGGTAACTCACCACCACTGAGAAC
GTAATCGCCGATTGACCATTCTTCGTCAATTTCGGTTTGGATCACGCGCTCATCTATACC
TTCGTAGCGACCGCACACCAGAATCAATTTTTGATTCGTTGCCAGTTCGCTGACGCCCGC
TTGATCAAGCTTGCGTCCCTGTGGTGACAGATAAATCACCTTTGCGCCTTCACCCGCCGC
GGCTTTTGCTGCATGAATGGCGTCCCGCAAGGGTTGCACCATCATTAACATCCCCGGTCC
GCCGCCGTAAGGACGATCGTCCACGGTACGGTGCCGGTCATGCGTGAAGTCGCGAGGACT
CCAACTCTGGATGCTCAGCAGGCCATTTTTAACTGCCCGGCCAGTTACCCCGTAATCGGT
AATTGCGCGGAACATTTCAGGAAACAGGCTAATTATGCCAATCCACAT

# Drug_Target_28_General_Function:
Involved in RNA binding

# Drug_Target_28_General_References:
12384590	Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F, Zhang X, Zhang J, Yang G, Wu H, Qu D, Dong J, Sun L, Xue Y, Zhao A, Gao Y, Zhu J, Kan B, Ding K, Chen S, Cheng H, Yao Z, He B, Chen R, Ma D, Qiang B, Wen Y, Hou Y, Yu J: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002 Oct 15;30(20):4432-41.
12704152	Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, Mayhew GF, Plunkett G 3rd, Rose DJ, Darling A, Mau B, Perna NT, Payne SM, Runyen-Janecky LJ, Zhou S, Schwartz DC, Blattner FR: Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun. 2003 May;71(5):2775-86.

# Drug_Target_28_HGNC_ID:
Not Available

# Drug_Target_28_HPRD_ID:
Not Available

# Drug_Target_28_ID:
4328

# Drug_Target_28_Locus:
Not Available

# Drug_Target_28_Molecular_Weight:
28423

# Drug_Target_28_Name:
tRNA

# Drug_Target_28_Number_of_Residues:
255

# Drug_Target_28_PDB_ID:
1P9P

# Drug_Target_28_Pathway:
Not Available

# Drug_Target_28_Pfam_Domain_Function:
PF01746	tRNA_m1G_MT

# Drug_Target_28_Protein_Sequence:
>tRNA
MWIGIISLFPEMFRAITDYGVTGRAVKNGLLSIQSWSPRDFTHDRHRTVDDRPYGGGPGM
LMMVQPLRDAIHAAKAAAGEGAKVIYLSPQGRKLDQAGVSELATNQKLILVCGRYEGIDE
RVIQTEIDEEWSIGDYVLSGGELPAMTLIDSVSRFIPGVLGHEASATEDSFAEGLLDCPH
YTRPEVLEGMEVPPVLLSGNHAEIRRWRLKQSLGRTWLRRPELLENLALTEEQARLLAEF
KTEHAQQQHKHDGMA

# Drug_Target_28_Reaction:
Not Available

# Drug_Target_28_Signals:
None

# Drug_Target_28_Specific_Function:
Specifically methylates guanosine-37 in various tRNAs (By similarity)

# Drug_Target_28_SwissProt_ID:
P0A876

# Drug_Target_28_SwissProt_Name:
TRMD_SHIFL

# Drug_Target_28_Synonyms:
EC 2.1.1.31
M1G- methyltransferase
guanine-N(1)-)-methyltransferase
tRNA [GM37] methyltransferase

# Drug_Target_28_Theoretical_pI:
5.59

# Drug_Target_28_Transmembrane_Regions:
None

# Drug_Target_29_Cellular_Location:
Not Available

# Drug_Target_29_Chromosome_Location:
Not Available

# Drug_Target_29_Drug_References:
Not Available

# Drug_Target_29_Essentiality:
Non-Essential

# Drug_Target_29_GenAtlas_ID:
Not Available

# Drug_Target_29_GenBank_ID_Gene:
M59236

# Drug_Target_29_GenBank_ID_Protein:
Not Available

# Drug_Target_29_GeneCard_ID:
Not Available

# Drug_Target_29_Gene_Name:
cobA

# Drug_Target_29_Gene_Sequence:
>843 bp
ATGATCGACGACCTCTTTGCCGGATTGCCGGCGCTCGAAAAAGGTTCGGTCTGGCTGGTC
GGCGCCGGCCCCGGCGATCCCGGCCTGTTGACGCTGCATGCGGCCAATGCGCTGCGCCAG
GCGGATGTGATCGTGCATGATGCGCTGGTCAACGAGGATTGCCTGAAGCTCGCGCGGCCG
GGCGCCGTGCTGGAGTTTGCGGGCAAGCGTGGCGGCAAGCCGTCGCCGAAGCAGCGCGAC
ATCTCGCTTCGCCTCGTCGAACTCGCGCGCGCCGGCAACCGGGTGCTGCGCCTCAAAGGC
GGCGATCCCTTCGTCTTCGGTCGCGGTGGCGAGGAGGCGCTGACGCTGGTCGAACACCAG
GTGCCGTTCCGAATCGTGCCCGGCATCACCGCCGGTATCGGCGGGCTTGCCTATGCCGGC
ATTCCCGTGACCCATCGCGAGGTCAACCACGCGGTCACTTTCCTGACTGGCCATGATTCC
TCCGGCCTGGTGCCGGATCGCATCAACTGGCAGGGCATCGCCAGCGGCTCGCCTGTCATC
GTCATGTACATGGCGATGAAACATATCGGCGCGATCACCGCCAACCTCATTGCCGGCGGC
CGCTCGCCGGACGAACCGGTCGCCTTCGTCTGCAACGCCGCGACGCCGCAGCAGGCGGTG
CTGGAAACGACGCTTGCGCGTGCAGAGGCCGATGTTGCGGCGGCAGGGCTGGAGCCGCCG
GCGATCGTCGTCGTCGGCGAGGTGGTGCGGCTGCGCGCAGCGCTCGACTGGATCGGCGCG
CTGGACGGGCGCAAGCTTGCCGCCGACCCGTTCGCCAATCGCATTCTCAGGAACCCGGCA
TGA

# Drug_Target_29_General_Function:
Involved in methyltransferase activity

# Drug_Target_29_General_References:
2211520	Crouzet J, Cauchois L, Blanche F, Debussche L, Thibaut D, Rouyez MC, Rigault S, Mayaux JF, Cameron B: Nucleotide sequence of a Pseudomonas denitrificans 5.4-kilobase DNA fragment containing five cob genes and identification of structural genes encoding S-adenosyl-L-methionine: uroporphyrinogen III methyltransferase and cobyrinic acid a,c-diamide synthase. J Bacteriol. 1990 Oct;172(10):5968-79.
2546914	Blanche F, Debussche L, Thibaut D, Crouzet J, Cameron B: Purification and characterization of S-adenosyl-L-methionine: uroporphyrinogen III methyltransferase from Pseudomonas denitrificans. J Bacteriol. 1989 Aug;171(8):4222-31.

# Drug_Target_29_HGNC_ID:
Not Available

# Drug_Target_29_HPRD_ID:
Not Available

# Drug_Target_29_ID:
4329

# Drug_Target_29_Locus:
Not Available

# Drug_Target_29_Molecular_Weight:
29253

# Drug_Target_29_Name:
Uroporphyrinogen-III C-methyltransferase

# Drug_Target_29_Number_of_Residues:
280

# Drug_Target_29_PDB_ID:
1S4D

# Drug_Target_29_Pathway:
Not Available

# Drug_Target_29_Pfam_Domain_Function:
PF00590	TP_methylase

# Drug_Target_29_Protein_Sequence:
>Uroporphyrinogen-III C-methyltransferase
MIDDLFAGLPALEKGSVWLVGAGPGDPGLLTLHAANALRQADVIVHDALVNEDCLKLARP
GAVLEFAGKRGGKPSPKQRDISLRLVELARAGNRVLRLKGGDPFVFGRGGEEALTLVEHQ
VPFRIVPGITAGIGGLAYAGIPVTHREVNHAVTFLTGHDSSGLVPDRINWQGIASGSPVI
VMYMAMKHIGAITANLIAGGRSPDEPVAFVCNAATPQQAVLETTLARAEADVAAAGLEPP
AIVVVGEVVRLRAALDWIGALDGRKLAADPFANRILRNPA

# Drug_Target_29_Reaction:
Not Available

# Drug_Target_29_Signals:
None

# Drug_Target_29_Specific_Function:
Catalyzes the methylation of both C-2 and C-7 of uroporphyrinogen III leading to precorrin-1 and precorrin-2; their oxidative esterification gives respectively factor I octamethyl ester and sirohydrochlorin

# Drug_Target_29_SwissProt_ID:
P21631

# Drug_Target_29_SwissProt_Name:
SUMT_PSEDE

# Drug_Target_29_Synonyms:
EC 2.1.1.107
SUMT
UROM
Urogen III methylase
Uroporphyrinogen III methylase

# Drug_Target_29_Theoretical_pI:
7.22

# Drug_Target_29_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
X01978

# Drug_Target_2_GenBank_ID_Protein:
61396

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
PAPS

# Drug_Target_2_Gene_Sequence:
>1002 bp
ATGGATGTTGTGTCGTTAGATAAACCGTTTATGTATTTTGAGGAAATTGATAATGAGTTA
GATTACGAACCAGAAAGTGCAAATGAGGTCGCAAAAAAACTGCCGTATCAAGGACAGTTA
AAACTATTACTAGGAGAATTATTTTTTCTTAGTAAGTTACAGCGACACGGTATATTAGAT
GGTGCCACCGTAGTGTATATAGGATCTGCTCCCGGTACACATATACGTTATTTGAGAGAT
CATTTCTATAATTTAGGAGTGATCATCAAATGGATGCTAATTGACGGCCGCCATCATGAT
CCTATTTTAAATGGATTGCGTGATGTGACTCTAGTGACTCGGTTCGTTGATGAGGAATAT
CTACGATCCATCAAAAAACAACTGCATCCTTCTAAGATTATTTTAATTTCTGATGTGAGA
TCCAAACGAGGAGGAAATGAACCTAGTACGGCGGATTTACTAAGTAATTACGCTCTACAA
AATGTCATGATTAGTATTTTAAACCCCGTGGCGTCTAGTCTTAAATGGAGATGCCCGTTT
CCAGATCAATGGATCAAGGACTTTTATATCCCACACGGTAATAAAATGTTACAACCTTTT
GCTCCTTCATATTCAGCTGAAATGAGATTATTAAGTATTTATACCGGTGAGAACATGAGA
CTGACTCGAGTTACCAAATCAGACGCTGTAAATTATGAAAAAAAGATGTACTACCTTAAT
AAGATCGTCCGTAACAAAGTAGTTGTTAACTTTGATTATCCTAATCAGGAATATGACTAT
TTTCACATGTACTTTATGCTGAGGACCGTGTACTGCAATAAAACATTTCCTACTACTAAA
GCAAAGGTACTATTTCTACAACAATCTATATTTCGTTTCTTAAATATTCCAACAACATCA
ACTGAAAAAGTTAGTCATGAACCAATACAACGTAAAATATCTAGCAAAAATTCTATGTCT
AAAAACAGAAATAGCAAGAGATCCGTACGCAGTAATAAATAG

# Drug_Target_2_General_Function:
Involved in mRNA (nucleoside-2'-O-)-methyltransferase activity

# Drug_Target_2_General_References:
1313572	Schnierle BS, Gershon PD, Moss B: Cap-specific mRNA (nucleoside-O2'-)-methyltransferase and poly(A) polymerase stimulatory activities of vaccinia virus are mediated by a single protein. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2897-901.
1670500	Gershon PD, Ahn BY, Garfield M, Moss B: Poly(A) polymerase and a dissociable polyadenylation stimulatory factor encoded by vaccinia virus. Cell. 1991 Sep 20;66(6):1269-78.
2987815	Plucienniczak A, Schroeder E, Zettlmeissl G, Streeck RE: Nucleotide sequence of a cluster of early and late genes in a conserved segment of the vaccinia virus genome. Nucleic Acids Res. 1985 Feb 11;13(3):985-98.
8612277	Hodel AE, Gershon PD, Shi X, Quiocho FA: The 1.85 A structure of vaccinia protein VP39: a bifunctional enzyme that participates in the modification of both mRNA ends. Cell. 1996 Apr 19;85(2):247-56.
9145102	Hodel AE, Gershon PD, Shi X, Wang SM, Quiocho FA: Specific protein recognition of an mRNA cap through its alkylated base. Nat Struct Biol. 1997 May;4(5):350-4.
9660928	Hodel AE, Gershon PD, Quiocho FA: Structural basis for sequence-nonspecific recognition of 5'-capped mRNA by a cap-modifying enzyme. Mol Cell. 1998 Feb;1(3):443-7.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2557

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
38888

# Drug_Target_2_Name:
Cap-specific mRNA

# Drug_Target_2_Number_of_Residues:
333

# Drug_Target_2_PDB_ID:
1VP3

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF01358	PARP_regulatory

# Drug_Target_2_Protein_Sequence:
>Cap-specific mRNA
MDVVSLDKPFMYFEEIDNELDYEPESANEVAKKLPYQGQLKLLLGELFFLSKLQRHGILD
GATVVYIGSAPGTHIRYLRDHFYNLGVIIKWMLIDGRHHDPILNGLRDVTLVTRFVDEEY
LRSIKKQLHPSKIILISDVRSKRGGNEPSTADLLSNYALQNVMISILNPVASSLKWRCPF
PDQWIKDFYIPHGNKMLQPFAPSYSAEMRLLSIYTGENMRLTRVTKSDAVNYEKKMYYLN
KIVRNKVVVNFDYPNQEYDYFHMYFMLRTVYCNKTFPTTKAKVLFLQQSIFRFLNIPTTS
TEKVSHEPIQRKISSKNSMSKNRNSKRSVRSNK

# Drug_Target_2_Reaction:
S-adenosyl-L-methionine + m7G(5')pppR-RNA = S-adenosyl-L-homocysteine + m7G(5')pppRm-RNA (mRNA containing a 2'-O-methylpurine cap)

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Methylates the ribose 2' OH group of the first transcribed nucleotide, thereby producing a 2'-o-methylpurine cap. Also act as a regulatory subunit of polymerase that creates the 3' poly(A) tail of mRNA's; the regulatory subunit binds to poly(A) but has no catalytic activity

# Drug_Target_2_SwissProt_ID:
P07617

# Drug_Target_2_SwissProt_Name:
PAP2_VACCW

# Drug_Target_2_Synonyms:
EC 2.1.1.57
PAP-S
Poly(A) polymerase regulatory subunit
Poly(A) polymerase small subunit
VP39

# Drug_Target_2_Theoretical_pI:
9.94

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_30_Cellular_Location:
Not Available

# Drug_Target_30_Chromosome_Location:
Not Available

# Drug_Target_30_Drug_References:
Not Available

# Drug_Target_30_Essentiality:
Non-Essential

# Drug_Target_30_GenAtlas_ID:
Not Available

# Drug_Target_30_GenBank_ID_Gene:
AP008226

# Drug_Target_30_GenBank_ID_Protein:
Not Available

# Drug_Target_30_GeneCard_ID:
Not Available

# Drug_Target_30_Gene_Name:
TTHA0667

# Drug_Target_30_Gene_Sequence:
>723 bp
CTAACCTCCCAGGGCCAAGGCGTCCACAGGCGCTTCCTTCTCGGCGAACACGCGCACCAC
CTCGCCCAGGATCCAGAGGGCGGGGGGACGCACCTCCACCTTGCCTTCCGCCACCTCTTC
CAGGCGGGCGTGGACCCGGCGCTCCTTGGGGGTGGAGGCCCGCTCCACGAAGAGGGTGGG
CTCCCTGGGGTCCCGCCCCAGGCGGAGGAGCTCCTTGGCGATCCAGACCCGGCGCCCCAC
CCCCATGAGGACCACCAGGGTGGGGACCCGGGCGAAGGGCCTGAGGTCCGGATACCCTCC
CCCCTCCAAGACCCCCGAGACCGCGGCGAAGCCGTGGGCGAGGCCCCGGTGGGTGAGGGG
AAGCCCGGAGGCGAGGAGGCTCGTCACCCCGGGGACGACCTCCACGGGGACGCCGTGCCG
GAGGAGGAAGAGCACCTCCTCCCCGCCCCGGCCGAAGACCATGGGGTCGCCCCCTTTGAG
GCGGACCACGAAGGGGTGGGCCCGGGCGTGGCGGAGGAGGAGGCGGTGGATTTCCTCCTG
CTTTTCGCTTTCCCCCTCCTCCTTCCCCACGTAGACCTTTTCCCCGGGGGCGAGGGCGAG
GACCCTCTCGTCCACGAGCCGGTCGTAGAGGACCACGGGGGCCTCCTTGAGGAGGCGGTA
GGCCTTGAGGGTCAGAAGCTCCGGGTCCCCGGGGCCCGCCCCCACCAGGTAGACCCTACC
CAT

# Drug_Target_30_General_Function:
Involved in methyltransferase activity

# Drug_Target_30_General_References:
Not Available

# Drug_Target_30_HGNC_ID:
Not Available

# Drug_Target_30_HPRD_ID:
Not Available

# Drug_Target_30_ID:
4330

# Drug_Target_30_Locus:
Not Available

# Drug_Target_30_Molecular_Weight:
26234

# Drug_Target_30_Name:
Hypothetical protein TTHA0667

# Drug_Target_30_Number_of_Residues:
240

# Drug_Target_30_PDB_ID:
1VA0

# Drug_Target_30_Pathway:
Not Available

# Drug_Target_30_Pfam_Domain_Function:
PF00590	TP_methylase

# Drug_Target_30_Protein_Sequence:
>Hypothetical protein TTHA0667
MGRVYLVGAGPGDPELLTLKAYRLLKEAPVVLYDRLVDERVLALAPGEKVYVGKEEGESE
KQEEIHRLLLRHARAHPFVVRLKGGDPMVFGRGGEEVLFLLRHGVPVEVVPGVTSLLASG
LPLTHRGLAHGFAAVSGVLEGGGYPDLRPFARVPTLVVLMGVGRRVWIAKELLRLGRDPR
EPTLFVERASTPKERRVHARLEEVAEGKVEVRPPALWILGEVVRVFAEKEAPVDALALGG

# Drug_Target_30_Reaction:
Not Available

# Drug_Target_30_Signals:
None

# Drug_Target_30_Specific_Function:
Not Available

# Drug_Target_30_SwissProt_ID:
Q5SKH6

# Drug_Target_30_SwissProt_Name:
Q5SKH6_THET8

# Drug_Target_30_Synonyms:
Not Available

# Drug_Target_30_Theoretical_pI:
9.37

# Drug_Target_30_Transmembrane_Regions:
None

# Drug_Target_31_Cellular_Location:
Not Available

# Drug_Target_31_Chromosome_Location:
Not Available

# Drug_Target_31_Drug_References:
Not Available

# Drug_Target_31_Essentiality:
Non-Essential

# Drug_Target_31_GenAtlas_ID:
Not Available

# Drug_Target_31_GenBank_ID_Gene:
J02757

# Drug_Target_31_GenBank_ID_Protein:
Not Available

# Drug_Target_31_GeneCard_ID:
Not Available

# Drug_Target_31_Gene_Name:
cheR

# Drug_Target_31_Gene_Sequence:
>867 bp
ATGACATCATCTCTGCCCTCCGGGCAAACGTCAGTATTGTTACAGATGACACAGCGCCTC
GCGCTGTCCGACGCGCATTTTCGTCGGATATGTCAATTAATCTACCAGCGCGCAGGGATC
GTGCTGGCCGACCATAAGCGGGATATGGTTTATAACCGCCTGGTCCGTCGGCTGCGTGCC
CTGGGACTGGATGATTTTGGCCGTTATCTCAGTATGCTGGAGGCTAATCAAAACAGCGCT
GAGTGGCAGGCTTTTATCAACGCTCTGACTACCAACCTGACCGCTTTTTTTCGCGAGGCG
CACCATTTTCCCATCCTTGCGGAACATGCGCGTCGCCGCCACGGCGAGTACCGCGTCTGG
AGTGCGGCGGCATCGACAGGAGAAGAACCTTACAGTATCGCCATTACGCTGGCGGATGCG
TTAGGGATGGCCCCCGGTCGCTGGAAAGTATTCGCCAGCGATATTGATACTGAAGTGCTG
GAAAAAGCGAGAAGCGGTATTTATCGCCTCAGCGAACTGAAAACGTTATCGCCGCAGCAG
CTACAACGTTACTTCATGCGCGGTACGGGGCCGCATGAAGGACTGGTGCGCGTGCGTCAG
GAACTGGCCAATTATGTTGAATTTTCCTCCGTTAATTTATTGGAAAAGCAGTACAACGTA
CCCGGTCCCTTTGACGCGATTTTTTGCCGTAACGTCATGATCTATTTTGATAAAACGACT
CAGGAGGACATTCTGCGCCGTTTTGTTCCACTCCTTAAACCTGACGGACTGTTGTTTGCC
GGTCACTCAGAAAACTTTAGCAACCTCGTGCGCGAGTTTAGCCTGCGCGGACAGACGGTG
TATGCGCTAAGTAAGGATAAAGCATGA

# Drug_Target_31_General_Function:
Involved in S-adenosylmethionine-dependent methyltransferase activity

# Drug_Target_31_General_References:
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.
3298235	Simms SA, Stock AM, Stock JB: Purification and characterization of the S-adenosylmethionine:glutamyl methyltransferase that modifies membrane chemoreceptor proteins in bacteria. J Biol Chem. 1987 Jun 25;262(18):8537-43.
9115443	Djordjevic S, Stock AM: Crystal structure of the chemotaxis receptor methyltransferase CheR suggests a conserved structural motif for binding S-adenosylmethionine. Structure. 1997 Apr 15;5(4):545-58.
9628482	Djordjevic S, Stock AM: Chemotaxis receptor recognition by protein methyltransferase CheR. Nat Struct Biol. 1998 Jun;5(6):446-50.

# Drug_Target_31_HGNC_ID:
Not Available

# Drug_Target_31_HPRD_ID:
Not Available

# Drug_Target_31_ID:
4331

# Drug_Target_31_Locus:
Not Available

# Drug_Target_31_Molecular_Weight:
32924

# Drug_Target_31_Name:
Chemotaxis protein methyltransferase

# Drug_Target_31_Number_of_Residues:
288

# Drug_Target_31_PDB_ID:
1AF7

# Drug_Target_31_Pathway:
Not Available

# Drug_Target_31_Pfam_Domain_Function:
PF01739	CheR
PF03705	CheR_N

# Drug_Target_31_Protein_Sequence:
>Chemotaxis protein methyltransferase
MTSSLPSGQTSVLLQMTQRLALSDAHFRRICQLIYQRAGIVLADHKRDMVYNRLVRRLRA
LGLDDFGRYLSMLEANQNSAEWQAFINALTTNLTAFFREAHHFPILAEHARRRHGEYRVW
SAAASTGEEPYSIAITLADALGMAPGRWKVFASDIDTEVLEKARSGIYRLSELKTLSPQQ
LQRYFMRGTGPHEGLVRVRQELANYVEFSSVNLLEKQYNVPGPFDAIFCRNVMIYFDKTT
QEDILRRFVPLLKPDGLLFAGHSENFSNLVREFSLRGQTVYALSKDKA

# Drug_Target_31_Reaction:
Not Available

# Drug_Target_31_Signals:
None

# Drug_Target_31_Specific_Function:
Methylation of the membrane-bound methyl-accepting chemotaxis proteins (MCP) to form gamma-glutamyl methyl ester residues in MCP

# Drug_Target_31_SwissProt_ID:
P07801

# Drug_Target_31_SwissProt_Name:
CHER_SALTY

# Drug_Target_31_Synonyms:
EC 2.1.1.80

# Drug_Target_31_Theoretical_pI:
9.60

# Drug_Target_31_Transmembrane_Regions:
None

# Drug_Target_32_Cellular_Location:
Cytoplasmic

# Drug_Target_32_Chromosome_Location:
Not Available

# Drug_Target_32_Drug_References:
Not Available

# Drug_Target_32_Essentiality:
Non-Essential

# Drug_Target_32_GenAtlas_ID:
Not Available

# Drug_Target_32_GenBank_ID_Gene:
M76681

# Drug_Target_32_GenBank_ID_Protein:
Not Available

# Drug_Target_32_GeneCard_ID:
Not Available

# Drug_Target_32_Gene_Name:
taqIM

# Drug_Target_32_Gene_Sequence:
>1266 bp
ATGGGCCTGCCACCCCTTCTGTCCTTACCTTCCAACTCCGCCCCCAGGAGCCTGGGCCGG
GTGGAGACCCCCCCGGAGGTGGTGGACTTCATGGTCTCCCTGGCCGAGGCGCCCAGGGGG
GGAAGGGTGCTGGAGCCCGCCTGCGCCCATGGGCCCTTCCTCCGGGCTTTCCGGGAGGCC
CACGGGACGGGCTACCGCTTCGTGGGGGTGGAGATAGACCCAAAAGCCCTGGACCTCCCC
CCCTGGGCCGAGGGCATCCTGGCGGACTTCCTCCTCTGGGAGCCGGGGGAGGCCTTTGAC
CTGATCCTGGGCAATCCGCCTTACGGCATCGTAGGAGAAGCCAGCAAATACCCCATTCAC
GTCTTCAAAGCGGTCAAGGACCTCTACAAGAAGGCCTTTTCCACCTGGAAGGGCAAGTAC
AACTTGTACGGGGCCTTTCTTGAAAAGGCCGTTCGCCTTCTTAAGCCTGGTGGGGTCCTC
GTCTTTGTAGTCCCGGCCACCTGGCTTGTCCTGGAGGATTTTGCCCTCCTTCGCGAGTTC
CTTGCCCGGGAAGGGAAAACATCTGTATACTACCTTGGCGAGGTTTTCCCGCAAAAAAAG
GTTAGCGCTGTAGTGATTCGCTTCCAGAAGAGCGGAAAAGGCCTTTCACTTTGGGATACC
CAAGAAAGCGAAAGCGGGTTCACGCCCATCCTCTGGGCTGAATATCCACATTGGGAAGGA
GAGATTATCCGCTTTGAAACAGAGGAGACGCGGAAGCTGGAAATATCGGGAATGCCACTG
GGAGACCTCTTTCATATCCGCTTCGCCGCAAGAAGCCCTGAATTCAAGAAACATCCAGCA
GTGAGAAAGGAACCGGGGCCAGGTCTTGTGCCTGTGCTCACAGGAAGAAATTTAAAGCCG
GGGTGGGTAGATTACGAGAAAAACCACTCCGGGCTTTGGATGCCCAAGGAAAGGGCCAAG
GAGCTCAGGGACTTCTATGCCACGCCCCACCTGGTGGTAGCCCACACCAAGGGGACTAGA
GTGGTGGCCGCTTGGGACGAAAGGGCCTACCCCTGGCGGGAGGAGTTCCACCTCCTGCCC
AAGGAAGGTGTGAGACTGGACCCCTCGTCCCTGGTGCAGTGGTTAAACTCCGAAGCGATG
CAGAAGCACGTCAGGACGCTTTATCGCGACTTCGTGCCCCACCTGACGCTGAGGATGCTA
GAAAGGCTTCCTGTAAGGAGGGAATATGGCTTCCACACAAGCCCAGAAAGCGCTCGAAAC
TTTTGA

# Drug_Target_32_General_Function:
Involved in nucleic acid binding

# Drug_Target_32_General_References:
1551602	Barany F, Slatko B, Danzitz M, Cowburn D, Schildkraut I, Wilson GG: The corrected nucleotide sequences of the TaqI restriction and modification enzymes reveal a thirteen-codon overlap. Gene. 1992 Mar 1;112(1):91-5.
2827113	Slatko BE, Benner JS, Jager-Quinton T, Moran LS, Simcox TG, Van Cott EM, Wilson GG: Cloning, sequencing and expression of the Taq I restriction-modification system. Nucleic Acids Res. 1987 Dec 10;15(23):9781-96.
7971991	Labahn J, Granzin J, Schluckebier G, Robinson DP, Jack WE, Schildkraut I, Saenger W: Three-dimensional structure of the adenine-specific DNA methyltransferase M.Taq I in complex with the cofactor S-adenosylmethionine. Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10957-61.

# Drug_Target_32_HGNC_ID:
Not Available

# Drug_Target_32_HPRD_ID:
Not Available

# Drug_Target_32_ID:
4332

# Drug_Target_32_Locus:
Not Available

# Drug_Target_32_Molecular_Weight:
47863

# Drug_Target_32_Name:
Modification methylase TaqI

# Drug_Target_32_Number_of_Residues:
421

# Drug_Target_32_PDB_ID:
1AQJ

# Drug_Target_32_Pathway:
Not Available

# Drug_Target_32_Pfam_Domain_Function:
Not Available

# Drug_Target_32_Protein_Sequence:
>Modification methylase TaqI
MGLPPLLSLPSNSAPRSLGRVETPPEVVDFMVSLAEAPRGGRVLEPACAHGPFLRAFREA
HGTAYRFVGVEIDPKALDLPPWAEGILADFLLWEPGEAFDLILGNPPYGIVGEASKYPIH
VFKAVKDLYKKAFSTWKGKYNLYGAFLEKAVRLLKPGGVLVFVVPATWLVLEDFALLREF
LAREGKTSVYYLGEVFPQKKVSAVVIRFQKSGKGLSLWDTQESESGFTPILWAEYPHWEG
EIIRFETEETRKLEISGMPLGDLFHIRFAARSPEFKKHPAVRKEPGPGLVPVLTGRNLKP
GWVDYEKNHSGLWMPKERAKELRDFYATPHLVVAHTKGTRVVAAWDERAYPWREEFHLLP
KEGVRLDPSSLVQWLNSEAMQKHVRTLYRDFVPHLTLRMLERLPVRREYGFHTSPESARN
F

# Drug_Target_32_Reaction:
Not Available

# Drug_Target_32_Signals:
None

# Drug_Target_32_Specific_Function:
This methylase recognizes the double-stranded sequence TCGA, causes specific methylation on A-4 on both strands and protects the DNA from cleavage by the TaqI endonuclease

# Drug_Target_32_SwissProt_ID:
P14385

# Drug_Target_32_SwissProt_Name:
MTTA_THEAQ

# Drug_Target_32_Synonyms:
Adenine-specific methyltransferase TaqI
EC 2.1.1.72
M.TaqI

# Drug_Target_32_Theoretical_pI:
9.39

# Drug_Target_32_Transmembrane_Regions:
None

# Drug_Target_33_Cellular_Location:
Cytoplasm (By similarity)

# Drug_Target_33_Chromosome_Location:
Not Available

# Drug_Target_33_Drug_References:
Not Available

# Drug_Target_33_Essentiality:
Non-Essential

# Drug_Target_33_GenAtlas_ID:
Not Available

# Drug_Target_33_GenBank_ID_Gene:
U30501

# Drug_Target_33_GenBank_ID_Protein:
Not Available

# Drug_Target_33_GeneCard_ID:
Not Available

# Drug_Target_33_Gene_Name:
pcm

# Drug_Target_33_Gene_Sequence:
>954 bp
TCAAATAGAACAGGATATATGTGAAAAAGCGTTGTAACCCACATGAAGCATGAGATACTC
GAAGCTCCTGTAGCCGCAGCTTTCCCACTGAGTTAAAAGGTTCTCTATCTCTGGAGCGTC
CCCGTAGATTCTCATCCTGTCATCGAGAAACTCTACCACGCCGTTTGGCCCAGCGTAGTA
GAACGTTCCATCAATCTCTGTGAGTCTCCTGGTGAGGAGATCCACCAGCTCCACGAAGAT
ATGAGAACGTACGAGTAAGATCTCTCTGTTGAATGGAAATTCTCTCAAAAGCTTTCTGTT
CCTCTCGAGAAGATTTCCGAGATTGCCCCCTGCCGTTATGAACCTGGTTTCCAGTTTGTA
GTTTCCCACAAGATACGGATCCTTTTTTTTGAACAGGAAAGCGGGCTGTCTTCTTGAAAG
TTTCAAATTGATAGGTACTATCACCCTCCCACCTTCTTTGAGTTGAGTGAACCACGTCTC
CGGCACCTCATCCACACCGACTGTTACGAAGATAACATCGTACGGGGAAAACTCCGGAAC
ACCGTAGTATCCATCGCCACAGACAAAAATAACGTTCTCTATTCCAAGGCGTTCCACGTT
CCTTTTCGCGATCTCGCAGATTTTCCTCGAATATTCCACGGAGACCACAAGGCCTTTCTC
ACCCACAACTCTGCTCATCACGGCAGCGTTGTAACCCGTTCCTCCGCCTATTTCGAGGAC
TCTCATTCCTTTGTCCAGACCCACCCACTCCATAAACAGCGCCATCAAAGAGGGCTGACT
GGAAGTGCTGTATTCTTCTCCATCATCGTAGGAAACCAGAACGATATCCTCGTAAACGTA
AGAGAGTGGGTAGGACTTCGTCAGGAACTCCTCACGGGGTATTTCCAGAAAAGCCTTCGC
GATGTGATCGCTCACACCGTACTTTTTAAGAATCCAAAAGAGCTTTTCTCTCAT

# Drug_Target_33_General_Function:
Involved in RNA binding

# Drug_Target_33_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.
8550470	Swanson RV, Sanna MG, Simon MI: Thermostable chemotaxis proteins from the hyperthermophilic bacterium Thermotoga maritima. J Bacteriol. 1996 Jan;178(2):484-9.
9784234	Ichikawa JK, Clarke S: A highly active protein repair enzyme from an extreme thermophile: the L-isoaspartyl methyltransferase from Thermotoga maritima. Arch Biochem Biophys. 1998 Oct 15;358(2):222-31.

# Drug_Target_33_HGNC_ID:
Not Available

# Drug_Target_33_HPRD_ID:
Not Available

# Drug_Target_33_ID:
4333

# Drug_Target_33_Locus:
Not Available

# Drug_Target_33_Molecular_Weight:
36400

# Drug_Target_33_Name:
Protein-L-isoaspartate O-methyltransferase

# Drug_Target_33_Number_of_Residues:
317

# Drug_Target_33_PDB_ID:
1DL5

# Drug_Target_33_Pathway:
Not Available

# Drug_Target_33_Pfam_Domain_Function:
PF01135	PCMT

# Drug_Target_33_Protein_Sequence:
>Protein-L-isoaspartate O-methyltransferase
MREKLFWILKKYGVSDHIAKAFLEIPREEFLTKSYPLSYVYEDIVLVSYDDGEEYSTSSQ
PSLMALFMEWVGLDKGMRVLEIGGGTGYNAAVMSRVVGEKGLVVSVEYSRKICEIAKRNV
ERLGIENVIFVCGDGYYGVPEFSPYDVIFVTVGVDEVPETWFTQLKEGGRVIVPINLKLS
RRQPAFLFKKKDPYLVGNYKLETRFITAGGNLGNLLERNRKLLREFPFNREILLVRSHIF
VELVDLLTRRLTEIDGTFYYAGPNGVVEFLDDRMRIYGDAPEIENLLTQWESCGYRSFEY
LMLHVGYNAFSHISCSI

# Drug_Target_33_Reaction:
Not Available

# Drug_Target_33_Signals:
None

# Drug_Target_33_Specific_Function:
Catalyzes the methyl esterification of L-isoaspartyl residues in peptides and proteins that result from spontaneous decomposition of normal L-aspartyl and L-asparaginyl residues. It plays a role in the repair and/or degradation of damaged proteins

# Drug_Target_33_SwissProt_ID:
Q56308

# Drug_Target_33_SwissProt_Name:
PIMT_THEMA

# Drug_Target_33_Synonyms:
EC 2.1.1.77
L-isoaspartyl protein carboxyl methyltransferase
PIMT
Protein L-isoaspartyl methyltransferase
Protein- beta-aspartate methyltransferase

# Drug_Target_33_Theoretical_pI:
5.31

# Drug_Target_33_Transmembrane_Regions:
None

# Drug_Target_34_Cellular_Location:
Not Available

# Drug_Target_34_Chromosome_Location:
Not Available

# Drug_Target_34_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_34_Essentiality:
Non-Essential

# Drug_Target_34_GenAtlas_ID:
Not Available

# Drug_Target_34_GenBank_ID_Gene:
Not Available

# Drug_Target_34_GenBank_ID_Protein:
Not Available

# Drug_Target_34_GeneCard_ID:
Not Available

# Drug_Target_34_Gene_Name:
COMTD1

# Drug_Target_34_Gene_Sequence:
Not Available

# Drug_Target_34_General_Function:
Not Available

# Drug_Target_34_General_References:
Not Available

# Drug_Target_34_HGNC_ID:
Not Available

# Drug_Target_34_HPRD_ID:
Not Available

# Drug_Target_34_ID:
7096

# Drug_Target_34_Locus:
Not Available

# Drug_Target_34_Molecular_Weight:
Not Available

# Drug_Target_34_Name:
Catechol O-methyltransferase domain-containing protein 1

# Drug_Target_34_Number_of_Residues:
0

# Drug_Target_34_PDB_ID:
Not Available

# Drug_Target_34_Pathway:
Not Available

# Drug_Target_34_Pfam_Domain_Function:
Not Available

# Drug_Target_34_Protein_Sequence:
Not Available

# Drug_Target_34_Reaction:
Not Available

# Drug_Target_34_Signals:
Not Available

# Drug_Target_34_Specific_Function:
Not Available

# Drug_Target_34_SwissProt_ID:
Q86VU5

# Drug_Target_34_SwissProt_Name:
CMTD1_HUMAN

# Drug_Target_34_Synonyms:
Not Available

# Drug_Target_34_Theoretical_pI:
Not Available

# Drug_Target_34_Transmembrane_Regions:
Not Available

# Drug_Target_35_Cellular_Location:
Not Available

# Drug_Target_35_Chromosome_Location:
Not Available

# Drug_Target_35_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_35_Essentiality:
Non-Essential

# Drug_Target_35_GenAtlas_ID:
Not Available

# Drug_Target_35_GenBank_ID_Gene:
L13453

# Drug_Target_35_GenBank_ID_Protein:
295169

# Drug_Target_35_GeneCard_ID:
Not Available

# Drug_Target_35_Gene_Name:
dnrK

# Drug_Target_35_Gene_Sequence:
>1071 bp
ATGACAGCCGAACCGACGGTCGCGGCCCGGCCGCAGCAGATCGACGCCCTCAGGACCCTG
ATCCGCCTCGGAAGCCTGCACACGCCCATGGTCGTCCGGACGGCCGCCACCCTGCGGCTC
GTCGACCACATCCTGGCCGGGGCCCGCACCGTGAAGGCCCTGGCGGCCAGGACAGACACC
CGGCCGGAAGCACTCCTGCGACTGATCCGCCACCTGGTGGCGATCGGACTGCTCGAGGAG
GACGCACCGGGCGAGTTCGTCCCGACCGAGGTCGGCGAGCTGCTCGCCGACGACCACCCA
GCCGCGCAGCGTGCCTGGCACGACCTGACGCAGGCCGTGGCGCGCGCCGACATCTCCTTC
ACCCGCCTCCCCGACGCCATCCGTACCGGCCGCCCCACGTACGAGTCCATCTACGGCAAG
CCGTTCTACGAGGACCTGGCCGGCCGCCCCGACCTGCGCGCGTCCTTCGACTCGCTGCTC
GCCTGCGACCAGGACGTCGCCTTCGACGCTCCGGCCGCCGCGTACGACTGGACGAACGTC
CGGCATGTGCTCGACGTGGGTGGCGGCAAGGGTGGTTTCGCCGCGGCCATCGCGCGCCGG
GCCCCGCACGTGTCGGCCACCGTGCTGGAGATGGCGGGCACCGTGGACACCGCCCGCTCC
TACCTGAAGGACGAGGGCCTCTCCGACCGTGTCGACGTCGTCGAGGGGGACTTCTTCGAG
CCGCTGCCCCGCAAGGCGGACGCGATCATCCTCTCTTTCGTCCTCCTCAACTGGCCGGAC
CACGACGCCGTCCGGATCCTCACCCGCTGCGCCGAGGCCCTGGAGCCCGGCGGGCGCATC
CTGATCCACGAGCGCGACGACCTCCACGAGAACTCGTTCAACGAACAGTTCACAGAGCTC
GATCTGCGGATGCTGGTCTTCCTCGGCGGTGCCCTGCGCACCCGCGAGAAGTGGGACGGC
CTGGCCGCGTCGGCGGGCCTCGTGGTCGAGGAGGTGCGGCAACTGCCGTCGCCGACCATC
CCGTACGACCTCTCGCTCCTCGTCCTTGCCCCCGCGGCCACCGGCGCCTGA

# Drug_Target_35_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_35_General_References:
7601857	Madduri K, Hutchinson CR: Functional characterization and transcriptional analysis of a gene cluster governing early and late steps in daunorubicin biosynthesis in Streptomyces peucetius. J Bacteriol. 1995 Jul;177(13):3879-84.
8509343	Madduri K, Torti F, Colombo AL, Hutchinson CR: Cloning and sequencing of a gene encoding carminomycin 4-O-methyltransferase from Streptomyces peucetius and its expression in Escherichia coli. J Bacteriol. 1993 Jun;175(12):3900-4.

# Drug_Target_35_HGNC_ID:
Not Available

# Drug_Target_35_HPRD_ID:
Not Available

# Drug_Target_35_ID:
3117

# Drug_Target_35_Locus:
Not Available

# Drug_Target_35_Molecular_Weight:
38783

# Drug_Target_35_Name:
Carminomycin 4-O-methyltransferase

# Drug_Target_35_Number_of_Residues:
356

# Drug_Target_35_PDB_ID:
1TW3

# Drug_Target_35_Pathway:
Not Available

# Drug_Target_35_Pfam_Domain_Function:
PF00891	Methyltransf_2

# Drug_Target_35_Protein_Sequence:
>Carminomycin 4-O-methyltransferase
MTAEPTVAARPQQIDALRTLIRLGSLHTPMVVRTAATLRLVDHILAGARTVKALAARTDT
RPEALLRLIRHLVAIGLLEEDAPGEFVPTEVGELLADDHPAAQRAWHDLTQAVARADISF
TRLPDAIRTGRPTYESIYGKPFYEDLAGRPDLRASFDSLLACDQDVAFDAPAAAYDWTNV
RHVLDVGGGKGGFAAAIARRAPHVSATVLEMAGTVDTARSYLKDEGLSDRVDVVEGDFFE
PLPRKADAIILSFVLLNWPDHDAVRILTRCAEALEPGGRILIHERDDLHENSFNEQFTEL
DLRMLVFLGGALRTREKWDGLAASAGLVVEEVRQLPSPTIPYDLSLLVLAPAATGA

# Drug_Target_35_Reaction:
Not Available

# Drug_Target_35_Signals:
None

# Drug_Target_35_Specific_Function:
Catalyzes the conversion of carminomycin to daunorubicin

# Drug_Target_35_SwissProt_ID:
Q06528

# Drug_Target_35_SwissProt_Name:
CM4T_STRPE

# Drug_Target_35_Synonyms:
COMT
EC 2.1.1.-

# Drug_Target_35_Theoretical_pI:
4.95

# Drug_Target_35_Transmembrane_Regions:
None

# Drug_Target_36_Cellular_Location:
Not Available

# Drug_Target_36_Chromosome_Location:
Not Available

# Drug_Target_36_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_36_Essentiality:
Non-Essential

# Drug_Target_36_GenAtlas_ID:
GAMT

# Drug_Target_36_GenBank_ID_Gene:
Z49878

# Drug_Target_36_GenBank_ID_Protein:
1212946

# Drug_Target_36_GeneCard_ID:
GAMT

# Drug_Target_36_Gene_Name:
GAMT

# Drug_Target_36_Gene_Sequence:
>711 bp
ATGAGCGCCCCCAGCGCGACCCCCATCTTCGCGCCCGGCGAGAACTGCAGCCCCGCGTGG
GGGGCGGCGCCCGCGGCCTACGACGCAGCGGACACGCACCTGCGCATCCTGGGCAAGCCG
GTGATGGAGCGCTGGGAGACCCCCTATATGCACGCGCTGGCCGCCGCCGCCTCCTCCAAA
GGGGGCCGGGTCCTGGAGGTGGGCTTTGGCATGGCCATCGCAGCGTCAAAGGTGCAGGAG
GCGCCCATTGATGAGCATTGGATCATCGAGTGCAATGACGGCGTCTTCCAGCGGCTCCGG
GACTGGGCCCCACGGCAGACACACAAGGTCATCCCCTTGAAAGGCCTGTGGGAGGATGTG
GCACCCACCCTGCCTGACGGTCACTTTGATGGGATCCTGTACGACACGTACCCACTCTCG
GAGGAGACCTGGCACACACACCAGTTCAACTTCATCAAGAACCACGCCTTTCGCCTGCTG
AAGCCGGGGGGCGTCCTCACCTACTGCAACCTCACCTCCTGGGGGGAGCTGATGAAGTCC
AAGTACTCAGACATCACCATCATGTTTGAGGAGACGCAGGTGCCCGCGCTGCTGGAGGCC
GGCTTCCGGAGGGAGAACATCCGTACGGAGGTGATGGCGCTGGTCCCACCGGCCGACTGC
CGCTACTACGCCTTCCCACAGATGATCACGCCCCTGGTGACCAAAGGCTGA

# Drug_Target_36_General_Function:
Involved in methyltransferase activity

# Drug_Target_36_General_References:
8547310	Isbrandt D, von Figura K: Cloning and sequence analysis of human guanidinoacetate N-methyltransferase cDNA. Biochim Biophys Acta. 1995 Dec 27;1264(3):265-7.
9325156	Jenne DE, Olsen AS, Zimmer M: The human guanidinoacetate methyltransferase (GAMT) gene maps to a syntenic region on 19p13.3, homologous to band C of mouse chromosome 10, but GAMT is not mutated in jittery mice. Biochem Biophys Res Commun. 1997 Sep 29;238(3):723-7.

# Drug_Target_36_HGNC_ID:
HGNC:4136

# Drug_Target_36_HPRD_ID:
03142

# Drug_Target_36_ID:
624

# Drug_Target_36_Locus:
19p13.3

# Drug_Target_36_Molecular_Weight:
26318

# Drug_Target_36_Name:
Guanidinoacetate N-methyltransferase

# Drug_Target_36_Number_of_Residues:
236

# Drug_Target_36_PDB_ID:
1XCL

# Drug_Target_36_Pathway:
Not Available

# Drug_Target_36_Pfam_Domain_Function:
Not Available

# Drug_Target_36_Protein_Sequence:
>Guanidinoacetate N-methyltransferase
MSAPSATPIFAPGENCSPAWGAAPAAYDAADTHLRILGKPVMERWETPYMHALAAAASSK
GGRVLEVGFGMAIAASKVQEAPIDEHWIIECNDGVFQRLRDWAPRQTHKVIPLKGLWEDV
APTLPDGHFDGILYDTYPLSEETWHTHQFNFIKNHAFRLLKPGGVLTYCNLTSWGELMKS
KYSDITIMFEETQVPALLEAGFRRENIRTEVMALVPPADCRYYAFPQMITPLVTKG

# Drug_Target_36_Reaction:
S-adenosyl-L-methionine + guanidinoacetate = S-adenosyl-L-homocysteine + creatine

# Drug_Target_36_Signals:
None

# Drug_Target_36_Specific_Function:
Not Available

# Drug_Target_36_SwissProt_ID:
Q14353

# Drug_Target_36_SwissProt_Name:
GAMT_HUMAN

# Drug_Target_36_Synonyms:
EC 2.1.1.2

# Drug_Target_36_Theoretical_pI:
6.09

# Drug_Target_36_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
AJ000758

# Drug_Target_3_GenBank_ID_Protein:
3724044

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
cbiF

# Drug_Target_3_Gene_Sequence:
>777 bp
ATGAAGTTATACATAATCGGAGCTGGACCCGGAGATCCAGATTTAATTACCGTAAAAGGC
TTAAAATTACTTCAGCAAGCAGATGTTGTTTTATACGCTGACTCACTAGTAAGTCAAGAT
CTAATTGCTAAGTCTAAACCAGGTGCTGAAGTGTTAAAAACAGCGGGTATGCATTTAGAA
GAAATGGTCGGTACTATGCTTGATCGCATGCGTGAAGGGAAAATGGTCGTGAGAGTACAT
ACGGGAGATCCGGCTATGTACGGAGCCATTATGGAACAAATGGTGCTTTTAAAAAGAGAA
GGTGTTGATATTGAAATCGTTCCGGGCGTCACGTCCGTATTCGCTGCTGCTGCAGCGGCT
GAAGCAGAATTAACCATTCCGGATTTGACTCAGACCGTTATTTTAACTCGGGCCGAAGGA
AGAACGCCTGTACCTGAGTTTGAAAAATTAACGGATTTAGCAAAACATAAATGTACGATT
GCGTTATTTTTAAGCGCGACGCTCACAAAAAAAGTAATGAAAGAATTTATAAATGCCGGT
TGGAGTGAGGATACGCCGGTTGTAGTAGTCTATAAAGCAACGTGGCCTGATGAAAAAATT
GTTCGCACGACGGTAAAAGACCTAGATGATGCTATGCGAACAAATGGCATTCGTAAGCAG
GCTATGATTTTGGCGGGCTGGGCACTTGACCCCCATATTCATGACAAAGATTATCGTTCA
AAACTCTACGATAAAACATTTACCCACGGCTTTCGCAAGGGAGTGAAATCGGAATGA

# Drug_Target_3_General_Function:
Coenzyme transport and metabolism

# Drug_Target_3_General_References:
9660189	Raux E, Schubert HL, Woodcock SC, Wilson KS, Warren MJ: Cobalamin (vitamin B12) biosynthesis--cloning, expression and crystallisation of the Bacillus megaterium S-adenosyl-L-methionine-dependent cobalt-precorrin-4 transmethylase CbiF. Eur J Biochem. 1998 Jun 1;254(2):341-6.
9742225	Raux E, Lanois A, Warren MJ, Rambach A, Thermes C: Cobalamin (vitamin B12) biosynthesis: identification and characterization of a Bacillus megaterium cobI operon. Biochem J. 1998 Oct 1;335 ( Pt 1):159-66.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
2551

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
28453

# Drug_Target_3_Name:
Cobalt-precorrin-4 C(11)-methyltransferase

# Drug_Target_3_Number_of_Residues:
258

# Drug_Target_3_PDB_ID:
2CBF

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00590	TP_methylase

# Drug_Target_3_Protein_Sequence:
>Cobalt-precorrin-4 C(11)-methyltransferase
MKLYIIGAGPGDPDLITVKGLKLLQQADVVLYADSLVSQDLIAKSKPGAEVLKTAGMHLE
EMVGTMLDRMREGKMVVRVHTGDPAMYGAIMEQMVLLKREGVDIEIVPGVTSVFAAAAAA
EAELTIPDLTQTVILTRAEGRTPVPEFEKLTDLAKHKCTIALFLSATLTKKVMKEFINAG
WSEDTPVVVVYKATWPDEKIVRTTVKDLDDAMRTNGIRKQAMILAGWALDPHIHDKDYRS
KLYDKTFTHGFRKGVKSE

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Catalyzes the methylation of C-11 in cobalt-precorrin-4 to form cobalt-precorrin-5

# Drug_Target_3_SwissProt_ID:
O87696

# Drug_Target_3_SwissProt_Name:
CBIF_BACME

# Drug_Target_3_Synonyms:
Cobalt- precorrin-3 methylase
EC 2.1.1.-

# Drug_Target_3_Theoretical_pI:
7.17

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Cytoplasm

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
PCMT1

# Drug_Target_4_GenBank_ID_Gene:
M93008

# Drug_Target_4_GenBank_ID_Protein:
180637

# Drug_Target_4_GeneCard_ID:
PCMT1

# Drug_Target_4_Gene_Name:
PCMT1

# Drug_Target_4_Gene_Sequence:
>687 bp
ATGGCCTGGAAATCCGGCGGCGCCAGCCACTCGGAGCTAATCCACAATCTCCGCAAAAAT
GGAATCATCAAGACAGATAAAGTATTTGAAGTGATGCTGGCTACAGACCGCTCCCACTAT
GCAAAATGTAACCCATACATGGATTCTCCACAATCAATAGGTTTCCAAGCAACAATCAGT
GCTCCACACATGCATGCATATGCGCTAGAACTTCTATTTGATCAGTTGCATGAAGGAGCT
AAAGCTCTTGATGTAGGATCTGGAAGTGGAATCCTTACTGCATGTTTTGCACGTATGGTT
GGATGTACTGGAAAAGTCATAGGAATTGATCACATTAAAGAGCTAGTAGATGACTCAGTA
AATAATGTCAGGAAGGACGATCCAACACTTCTGTCTTCAGGGAGAGTACAGCTTGTTGTG
GGGGATGGAAGAATGGGATATGCTGAAGAAGCCCCTTATGATGCCATTCATGTGGGAGCT
GCAGCCCCTGTTGTACCCCAGGCGCTAATAGATCAGTTAAAGCCCGGAGGAAGATTGATA
TTGCCTGTTGGTCCTGCAGGCGGAAACCAAATGTTGGAGCAGTATGACAAGCTACAAGAT
GGCAGCATCAAAATGAAGCCTCTGATGGGGGTGATATACGTGCCTTTAACAGATAAAGAA
AAGCAGTGGTCCAGGGATGAATTGTAA

# Drug_Target_4_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_4_General_References:
10496068	DeVry CG, Clarke S: Polymorphic forms of the protein L-isoaspartate (D-aspartate) O-methyltransferase involved in the repair of age-damaged proteins. J Hum Genet. 1999;44(5):275-88.
1339271	MacLaren DC, Kagan RM, Clarke S: Alternative splicing of the human isoaspartyl protein carboxyl methyltransferase RNA leads to the generation of a C-terminal -RDEL sequence in isozyme II. Biochem Biophys Res Commun. 1992 May 29;185(1):277-83.
1998518	Ingrosso D, Kagan RM, Clarke S: Distinct C-terminal sequences of isozymes I and II of the human erythrocyte L-isoaspartyl/D-aspartyl protein methyltransferase. Biochem Biophys Res Commun. 1991 Feb 28;175(1):351-8.
2684970	Ingrosso D, Fowler AV, Bleibaum J, Clarke S: Sequence of the D-aspartyl/L-isoaspartyl protein methyltransferase from human erythrocytes. Common sequence motifs for protein, DNA, RNA, and small molecule S-adenosylmethionine-dependent methyltransferases. J Biol Chem. 1989 Nov 25;264(33):20131-9.
3167043	Gilbert JM, Fowler A, Bleibaum J, Clarke S: Purification of homologous protein carboxyl methyltransferase isozymes from human and bovine erythrocytes. Biochemistry. 1988 Jul 12;27(14):5227-33.
7592526	Takeda R, Mizobuchi M, Murao K, Sato M, Takahara J: Characterization of three cDNAs encoding two isozymes of an isoaspartyl protein carboxyl methyltransferase from human erythroid leukemia cells. J Biochem (Tokyo). 1995 Apr;117(4):683-5.
8074695	Tsai W, Clarke S: Amino acid polymorphisms of the human L-isoaspartyl/D-aspartyl methyltransferase involved in protein repair. Biochem Biophys Res Commun. 1994 Aug 30;203(1):491-7.
8914929	DeVry CG, Tsai W, Clarke S: Structure of the human gene encoding the protein repair L-isoaspartyl (D-aspartyl) O-methyltransferase. Arch Biochem Biophys. 1996 Nov 15;335(2):321-32.

# Drug_Target_4_HGNC_ID:
HGNC:8728

# Drug_Target_4_HPRD_ID:
08908

# Drug_Target_4_ID:
1998

# Drug_Target_4_Locus:
6q24-q25

# Drug_Target_4_Molecular_Weight:
24651

# Drug_Target_4_Name:
Protein-L-isoaspartate(D-aspartate) O-methyltransferase

# Drug_Target_4_Number_of_Residues:
227

# Drug_Target_4_PDB_ID:
1KR5

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF01135	PCMT

# Drug_Target_4_Protein_Sequence:
>Protein-L-isoaspartate(D-aspartate) O-methyltransferase
MAWKSGGASHSELIHNLRKNGIIKTDKVFEVMLATDRSHYAKCNPYMDSPQSIGFQATIS
APHMHAYALELLFDQLHEGAKALDVGSGSGILTACFARMVGCTGKVIGIDHIKELVDDSI
NNVRKDDPTLLSSGRVQLVVGDGRMGYAEEAPYDAIHVGAAAPVVPQALIDQLKPGGRLI
LPVGPAGGNQMLEQYDKLQDGSIKMKPLMGVIYVPLTDKEKQWSRWK

# Drug_Target_4_Reaction:
S-adenosyl-L-methionine + protein L-isoaspartate = S-adenosyl-L-homocysteine + protein L-isoaspartate alpha-methyl ester

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Catalyzes the methyl esterification of L-isoaspartyl and D-aspartyl residues in peptides and proteins that result from spontaneous decomposition of normal L-aspartyl and L-asparaginyl residues. It plays a role in the repair and/or degradation of damaged proteins. Acts on microtubule-associated protein 2, calreticulin, clathrin light chains a and b, Ubiquitin carboxyl- terminal hydrolase isozyme L1, phosphatidylethanolamine-binding protein 1, stathmin, beta-synuclein and alpha-synuclein

# Drug_Target_4_SwissProt_ID:
P22061

# Drug_Target_4_SwissProt_Name:
PIMT_HUMAN

# Drug_Target_4_Synonyms:
D-aspartate
EC 2.1.1.77
L-isoaspartyl protein carboxyl methyltransferase
PIMT
Protein L- isoaspartyl/D-aspartyl methyltransferase
Protein-beta-aspartate methyltransferase

# Drug_Target_4_Theoretical_pI:
7.25

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Cytoplasmic

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
M19197

# Drug_Target_5_GenBank_ID_Protein:
323655

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
Not Available

# Drug_Target_5_Gene_Sequence:
>10167 bp
ATGAATGACCAACGGAAAAAGGCGAGAAACACGCCTTTCAATATGCTGAAACGCGAGAGA
AACCGCGTGTCAACTGTACAACAGTTGACAAAGAGATTCTCACTTGGAATGCTGCAGGGA
CGAGGACCACTAAAATTGTTCATGGCCCTGGTGGCATTCCTTCGTTTCCTAACAATCCCA
CCAACAGCAGGGATATTAAAAAGATGGGGAACAATTAAAAAATCAAAGGCTATTAATGTT
CTGAGAGGCTTCAGGAAAGAGATTGGAAGGATGCTGAATATCTTAAACAGGAGACGTAGA
ACTGCAGGCATGATCATCATGCTGATTCCAACAGTGATGGCGTTTCATCTGACCACACGC
AACGGAGAACCACACATGATCGTCAGTAGACAAGAAAAAGGGAAAAGCCTTCTGTTTAAG
ACAAAGGACGGCACGAACATGTGTACCCTCATGGCCATGGACCTTGGTGAGTTGTGTGAA
GACACAATCACGTATAAATGTCCCTTTCTCAAGCAGAACGAACCAGAAGACATAGATTGT
TGGTGCAACTCCACGTCCACATGGGTAACTTATGGGACATGTACCACCACAGGAGAGCAC
AGAAGAGAAAAAAGATCAGTGGCGCTTGTTCCACACGTGGGAATGGGATTGGAGACACGA
ACTGAAACATGGATGTCATCAGAAGGGGCCTGGAAACATGCCCAGAGAATTGAAACTTGG
ATTCTGAGACATCCAGGCTTTACCATAATGGCCGCAATCCTGGCATACACCATAGGAACG
ACGCATTTCCAAAGAGTCCTGATATTCATCCTACTGACAGCCATCGCTCCTTCAATGACA
ATGCGCTGCATAGGAATATCAAATAGGGACTTTGTGGAAGGAGTGTCAGGAGGGAGTTGG
GTTGACATAGTTTTAGAACATGGAAGTTGTGTGACGACGATGGCAAAAAATAAACCAACA
CTGGACTTTGAACTGATAAAAACAGAAGCCAAACAACCCGCCACCTTAAGGAAGTACTGT
ATAGAGGCTAAACTGACCAACACGACAACAGACTCGCGCTGCCCAACACAAGGGGAACCC
ACCCTGAATGAAGAGCAGGACAAAAGGTTTGTCTGCAAACATTCCATGGTAGACAGAGGA
TGGGGAAATGGATGTGGATTATTTGGAAAAGGAGGCATCGTGACCTGTGCCATGTTCACA
TGCAAAAAGAACATGGAGGGAAAAATTGTGCAGCCAGAAAACCTGGAATACACTGTCGTT
ATAACACCTCATTCAGGGGAAGAACATGCAGTCGGAAATGACACAGGAAAACATGGTAAA
GAAGTCAAGATAACACCACAGAGCTCCATCACAGAGGCGGAACTGACAGGCTATGGCACT
GTTACGATGGAGTGCTCTCCAAGAACGGGCCTCGACTTCAATGAGATGGTGTTGCTGCAA
ATGAAAGACAAAGCTTGGCTGGTGCACAGACAATGGTTCCTAGACCTACCGTTGCCATGG
CTGCCCGGAGCAGACACACAAGGATCAAATTGGATACAGAAAGAGACACTGGTCACCTTC
AAAAATCCCCATGCGAAAAAACAGGATGTTGTTGTCTTAGGATCCCAAGAGGGGGCCATG
CATACAGCACTCACAGGGGCTACGGAAATCCAGATGTCATCAGGAAACCTGCTGTTCACA
GGACATCTTAAGTGCAGGCTGAGAATGGACAAATTACAACTTAAAGGGATGTCATACTCC
ATGTGCACAGGAAAGTTTAAAGTTGTGAAGGAAATAGCAGAAACACAACATGGAACAATA
GTCATTAGAGTACAATATGAAGGAGACGGCTCTCCATGCAAGACCCCTTTTGAGATAATG
GATCTGGAAAAAAGACATGTTTTGGGCCGCCTGACCACAGTCAACCCAATTGTAACAGAA
AAGGACAGTCCAGTCAACATAGAAGCAGAACCTCCATTCGGAGACAGCTACATCATCATA
GGAGTGGAACCAGGACAATTGAAGCTGGACTGGTTCAAGAAAGGAAGTTCCATCGGCCAA
ATGTTTGAGACAACAATGAGGGGAGCGAAAAGAATGGCCATTTTGGGCGACACAGCCTGG
GATTTTGGATCTCTGGGAGGAGTGTTCACATCAATAGGAAAGGCTCTCCACCAGGTTTTT
GGAGCAATCTACGGGGCTGCTTTCAGTGGGGTCTCATGGACTATGAAGATCCTCATAGGA
GTTATCATCACATGGATAGGAATGAACTCACGTAGCACATCACTGTCTGTGTCACTGGTA
TTAGTGGGAATCGTGACACTGTACTTGGGAGTTATGGTGCAGGCCGATAGTGGTTGCGTT
GTGAGCTGGAAGAACAAAGAACTAAAATGTGGCAGTGGAATATTCGTCACAGATAACGTG
CATACATGGACAGAACAATACAAGTTCCAACCAGAATCCCCTTCAAAACTGGCTTCAGCC
ATCCAGAAAGCTCATGAAGAGGGCATCTGTGGAATCCGCTCAGTAACAAGACTGGAAAAT
CTTATGTGGAAACAAATAACATCAGAATTGAATCATATTCTATCAGAAAATGAAGTGAAA
CTGACCATCATGACAGGAGACATCAAAGGAATCATGCAGGTAGGAAAACGATCTCTGCGG
CCTCAACCCACTGAGTTGAGGTATTCATGGAAAACATGGGGTAAAGCGAAAATGCTCTCC
ACAGAACTCCATAATCAGACCTTCCTCATTGATGGTCCCGAAACAGCAGAATGCCCCAAC
ACAAACAGAGCTTGGAATTCACTAGAAGTTGAGGACTACGGCTTTGGAGTATTCACTACC
AATATATGGCTAAGATTGAGAGAAAAGCAGGATGCATTTTGTGACTCAAAACTCATGTCA
GCGGCCATAAAGGACAACAGAGCCGTCCATGCTGATATGGGTTATTGGATAGAAAGCGCA
CTCAATGATACATGGAAGATAGAGAAAGCTTCTTTCATTGAAGTCAAAAGTTGCCACTGG
CCAAAGTCACACACTCTATGGAGTAATGGAGTGCTAGAAAGCGAGATGGTAATTCCAAAG
AATTTCGCTGGACCAGTGTCACAACATAATAACAGACCAGGCTATCACACACAAACAGCA
GGACCTTGGCATCTAGGCAAGCTTGAGATGGACTTTGATTTCTGCGAAGGGACTACAGTG
GTGGTAACCGAGGACTGTGGAAACAGAGGGCCCTCTTTAAGAACAACCACTGCCTCAGGA
AAACTCATAACGGAATGGTGTTGTCGATCTTGCACACTACCACCACTAAGATACAGAGGT
GAGGATGGATGCTGGTACGGGATGGAAATCAGACCATTGAAAGAGAAAGAAGAAAATCTG
GTCAGTTCTCTGGTCACAGCCGGACATGGGCAGATTGATAATTTCTCATTAGGAATCTTG
GGAATGGCACTGTTCCTTGAAGAAATGCTCAGGACTCGAGTAGGAACGAAACATGCAATA
TTACTAGTCGCAGTTTCTTTCGTAACGTTAATCACAGGGAACATGTCTTTTAGAGACCTG
GGAAGAGTGATGGTTATGGTGGGTGCCACCATGACAGATGACATAGGCATGGGTGTGACT
TATCTTGCTCTACTAGCAGCTTTCAAAGTCAGACCAACCTTTGCAGCTGGACTGCTCTTG
AGAAAACTGACCTCCAAGGAATTAATGATGACCACCATAGGAATCGTTCTTCTCTCCCAG
AGTAGCATACCAGAGACCATTCTTGAACTGACCGATGCGTTAGCTTTAGGCATGATGGTC
CTCAAGATGGTGAGAAACATGGAAAAATATCAGCTGGCAGTGACCATCATGGCTATTTTG
TGCGTCCCAAATGCTGTGATATTACAGAACGCATGGAAAGTGAGTTGCACAATATTGGCA
GTGGTGTCTGTTTCCCCCCTGTTCTTAACATCCTCACAACAGAAAGCGGACTGGATACCA
TTAGCGTTGACGATCAAAGGCCTCAATCCAACAGCCATTTTTCTAACAACCCTCTCAAGA
ACCAGCAAGAAAAGGAGCTGGCCTTTAAATGAGGCCATCATGGCGGTTGGGATGGTGAGT
ATCTTGGCCAGCTCTCTCTTAAAGAATGACACCCCCATGACAGGACCATTAGTGGCTGGA
GGGCTTCTTACTGTGTGCTACGTACTAACTGGGCGGTCAGCCGATCTGGAACTAGAGAGA
GCTACCGATGTCAAATGGGATGACCAGGCAGAGATATCAGGTAGCAGTCCAATTCTGTCA
ATAACAATATCAGAAGATGGCAGCATGTCAATAAAGAATGAAGAGGAAGAGCAAACATTG
ACTATACTCATTAGAACAGGATTGCTTGTGATCTCAGGACTCTTTCCGGTATCAATACCA
ATTACAGCAGCAGCATGGTACCTGTGGGAAGTAAAGAAACAACGGGCTGGAGTGTTGTGG
GATGTCCCCTCACCACCACCCGTGGGAAAGGCTGAATTGGAAGATGGAGCCTACAGAATC
AAGCAAAAAGGAATCCTTGGATATTCCCAGATCGGAGCTGGAGTTTACAAAGAAGGAACA
TTTCACACAATGTGGCACGTCACACGTGGCGCTGTCCTAATGCATAAGGGGAAGAGGATT
GAACCATCATGGGCGGACGTCAAGAAAGACTTAATATCATATGGAGGAGGTTGGAAGCTA
GAAGGAGAATGGAAAGAAGGAGAAGAAGTCCAGGTCTTGGCATTGGAGCCTGGGAAAAAT
CCAAGAGCCGTCCAAACAAAACCTGGCCTTTTTAGAACCAATACTGGAACCATAGGTGCC
GTATCTCTGGACTTTTCCCCTGGGACGTCAGGATCTCCAATCGTCGACAAAAAAGGAAAA
GTTGTAGGCCTCTATGGCAATGGTGTCGTTACAAGGAGTGGAGCATATGTGAGTGCCATA
GCTCAGACTGAAAAAAGCATTGAAGACAATCCAGAGATTGAAGATGACATCTTTCGAAAG
AGAAGATTGACTATCATGGATCTCCACCCAGGAGCAGGAAAGACAAAGAGATACCTCCCG
GCCATAGTCAGAGAGGCCATAAAAAGAGGCTTGAGAACACTAATCCTAGCCCCCACTAGA
GTCGTGGCAGCTGAAATGGAGGAAGCCCTTAGAGGACTTCCAATAAGATACCAAACTCCA
GCTATCAGGGCTGAGCACACCGGGCGGGAGATTGTGGACTTAATGTGTCATGCCACATTT
ACCATGAGGCTGCTATCACCAATCAGGGTGCCAAATTACAACCTGATCATCATGGACGAA
GCCCATTTTACAGATCCAGCAAGCATAGCAGCTAGGGGATACATCTCAACTCGAGTGGAG
ATGGGTGAGGCAGCTGGAATTTTTATGACAGCCACTCCTCCGGGTAGCAGAGATCCATTT
CCTCAGAGTAATGCACCAATTATGGACGAAGAAAGAGAAATCCCGGAACGTTCATGGAAC
TCCGGGCACGAGTGGGTCACGGATTTTAAAGGAAAGACTGTCTGGTTTGTTCCAAGCATA
AAAACCGGAAATGACATAGCAGCCTGCCTGAGAAAGAATGGAAAGAGGGTGATACAACTC
AGTAGGAAGACCTTTGATTCTGAATATGTCAAGACTAGAACCAATGACTGGGATTTCGTG
GTTACAACTGACATCTCGGAAATGGGTGCCAACTTTAAAGCTGAGAGGGTTATAGACCCC
AGACGCTGCATGAAACCAGTTATACTGACAGACGGCGAAGAGCGGGTGATTCTGGCAGGA
CCCATGCCAGTGACCCACTCTAGTGCAGCACAAAGAAGAGGGAGAATAGGAAGGAATCCA
AGGAATGAAAATGATCAATATATATATATGGGGGAACCCCTGGAAAATGATGAAGACTGT
GCGCACTGGAAGGAAGCTAAGATGCTCCTAGATAACATCAACACACCTGAAGGAATCATT
CCCAGCATGTTCGAGCCAGAGCGTGAAAAGGTGGATGCCATTGACGGTGAATATCGCTTG
AGAGGAGAAGCACGGAAAACTTTTGTGGACCTAATGAGAAGAGGAGACCTACCAGTCTGG
TTGGCTTATAAAGTGGCTGCTGAAGGTATCAACTACGCAGACAGAAGATGGTGTTTTGAC
GGAACCAGAAACAATCAAATCTTGGAAGAAAATGTGGAAGTGGAAATCTGGACAAAGGAA
GGGGAAAGGAAAAAATTGAAACCTAGATGGTTAGATGCTAGGATCTACTCCGACCCACTG
GCGCTAAAAGAATTCGCAGCCGGAAGAAAGTCCCTAACCCTGAACCTAATCACAGAGATG
GGCAGACTCCCAACTTTTATGACTCAGAAGGCCAGAGATGCACTAGACAACTTGGCGGTG
CTGCACACGGCTGAAGCGGGTGGAAAGGCATACAATCATGCTCTCAGTGAACTACCGGAG
ACCCTGGAGACATTGCTTTTGCTGACACTGTTGGCCACAGTCACGGGAGGAATCTTTCTA
TTCCTGATGAGCGGAAGGGGTATAGGGAAGATGACCCTGGGAATGTGCTGCATAATCACG
GCCAGCATCCTCTTATGGTATGCACAAATACAACCACATTGGATAGCAGCTTCAATAATA
TTGGAGTTCTTTCTCATAGTCTTGCTCATTCCAGAACCAGAAAAGCAGAGGACACCCCAG
GATAACCAATTGACTTATGTCATCATAGCCATCCTCACAGTGGTGGCCGCAACCATGGCA
AACGAAATGGGTTTTCTGGAAAAAACAAAGAAAGACCTCGGACTGGGAAACATTGCAACT
CAGCAACCTGAGAGCAACATTCTGGACATAGATCTACGTCCTGCATCAGCATGGACGTTG
TATGCCGTGGCCACAACATTTATCACACCAATGTTGAGACATAGCATTGAAAATTCCTCA
GTAAATGTGTCCCTAACAGCCATAGCTAACCAAGCCACAGTGCTAATGGGTCTCGGGAAA
GGATGGCCATTGTCAAAGATGGACATTGGAGTTCCCCTCCTTGCTATTGGGTGTTACTCA
CAAGTCAACCCTATAACCCTCACAGCGGCTCTTCTTTTATTGGTAGCACATTATGCCATC
ATAGGACCGGGACTTCAAGCCAAAGCAACCAGAGAAGCTCAGAAAAGAGCAGCAGCGGGC
ATCATGAAAAACCCAACTGTGGATGGAATAACAGTGATAGATCTAGATCCAATACCCTAT
GATCCAAAGTTTGAAAAGCAGTTGGGACAAGTAATGCTCCTAGTCCTCTGTGTGACCCAA
GTGCTGATGATGAGGACTACGTGGGCTTTGTGTGAAGCCTTAACTCTAGCAACCGGACCC
GTGTCCACATTGTGGGAAGGAAATCCAGGGAGATTCTGGAACACAACCATTGCAGTGTCA
ATGGCAAACATCTTTAGAGGGAGTTACCTGGCTGGAGCTGGACTTCTCTTTTCTATCATG
AAGAACACAACCAGCACGAGAAGAGGAACTGGCAACATAGGAGAAACGCTAGGAGAGAAA
TGGAAAAGCAGGCTGAACGCATTGGGGAAAAGTGAATTCCAGATCTATAAAAAAAGTGGA
ATTCAAGAAGTGGACAGAACCTTAGCAAAAGAAGGCATTAAAAGAGGAGAAACGGATCAT
CACGCTGTGTCGCGAGGCTCAGCAAAACTGAGATGGTTCGTTGAAAGAAATTTGGTCACA
CCAGAAGGGAAAGTAGTGGACCTTGGTTGCGGCAGAGGGGGCTGGTCATACTATTGTGGA
GGATTAAAGAATGTAAGAGAAGTCAAAGGCTTAACAAAAGGAGGACCAGGACACGAAGAA
CCTATCCCTATGTCAACATATGGGTGGAATCTAGTACGCTTACAGAGCGGAGTTGACGTT
TTTTTTGTTCCACCAGAGAAGTGTGACACATTGTTGTGTGACATAGGGGAATCATCACCA
AATCCCACGGTAGAAGCGGGACGAACACTCAGAGTCCTTAACCTAGTGGAAAATTGGTTG
AACAATAACACCCAATTTTGCGTAAAGGTTCTTAACCCGTACATGCCCTCAGTCATTGAA
AGAATGGAAACCTTACAACGGAAATACGGAGGAGCCTTGGTGAGAAATCCACTCTCACGG
AATTCCACACATGAGATGTACTGGGTGTCCAATGCTTCCGGGAACATAGTGTCATCAGTG
AACATGATTTCAAGAATGCTGATTAACAGATTCACCATGAGACACAAGAAGGCCACCTAT
GAGCCAGATGTCGACCTCGGAAGCGGAACCCGCAATATTGGAATTGAAAGTGAGACACCG
AACCTAGACATAATTGGGAAAAGAATAGAAAAAATAAAACAAGAGCATGAAACGTCATGG
CACTATGACCAAGACCACCCATACAAAACATGGGCTTACCATGGCAGCTATGAAACAAAA
CAGACTGGATCAGCATCATCCATGGTGAACGGAGTAGTCAGATTGCTGACAAAACCCTGG
GACGTTGTTCCAATGGTGACACAGATGGCAATGACAGACACAACTCCTTTCGGACAACAG
CGCGTCTTCAAAGAGAAGGTGGATACGAGAACCCAAGAACCAAAAGAAGGCACAAAAAAA
CTAATGAAAATCACGGCAGAGTGGCTCTGGAAAGAACTAGGAAAGAAAAAGACACCTAGA
ATGTGCACCAGAGAAGAATTCACAAAAAAGGTGAGAAGCAATGCAGCCTTGGGGGCCATA
TTTACCGATGAGAACAAGTGGAAATCGGCGCGTGAGGCTGTTGAAGATAGTAGGTTTTGG
GAGCTGGTTGACAAGGAAAGAAACCTCCATCTTGAAGGGAAATGTGAAACATGTGTATAC
AACATGATGGGAAAAAGAGAGAAAAAACTAGGAGAGTTTGGTAAAGCAAAAGGCAGCAGA
GCCATATGGTACATGTGGCTCGGAGCACGCTTCTTAGAGTTCGAAGCCCTAGGATTTTTG
AATGAAGACCATTGGTTCTCCAGAGAGAACTCCCTGAGTGGAGTAGAAGGAGAAGGGCTG
CATAAGCTAGGTTACATCTTAAGAGAGGTGAGCAAGAAAGAAGGAGGAGCAATGTATGCC
GATGACACCGCAGGCTGGGACACAAGAATCACAATAGAGGATTTAAAAAATGAAGAAATG
ATAACGAACCACATGGCAGGAGAACACAAGAAACTTGCCGAGGCCATTTTTAAATTGACG
TATCAAAACAAGGTGGTGCGTGTGCAAAGACCAACACCAAGAGGCACAGTAATGGACATC
ATATCGAGAAGAGACCAAAGGGGTAGTGGACAAGTTGGTACCTATGGCCTCAACACTTTC
ACCAACATGGAAGCACAACTAATTAGGCAAATGGAGGGGGAAGGAATCTTCAAAAGCATC
CAGCACTTGACAGCCTCAGAAGAAATCGCTGTGCAAGATTGGCTAGCAAGAGTAGGGCGT
GAAAGGTTGTCAAGAATGGCCATCAGTGGAGATGATTGTGTTGTGAAACCTTTAGATGAT
AGATTTGCAAGAGCTCTAACAGCTCTAAATGACATGGGAAAGGTTAGGAAGGACATACAG
CAATGGGAGCCCTCAAGAGGATGGAACGACTGGACACAGGTACCCTTCTGTTCACACCAT
TTTCACGAGTTAATTATGAAAGATGGTCGCACACTCGTAGTTCCATGCAGAAACCAAGAT
GAATTGATCGGCAGAGCCCGAATTTCCCAGGGAGCTGGGTGGTCTTTACGGGAGACGGCC
TGTTTGGGGAAGTCTTACGCCCAAATGTGGAGCTTGATGTACTTCCACAGACGTGATCTC
AGGCTAGCGGCAAATGCCATCTGCTCGGCAGTCCCGTCACACTGGGTTCCAACAAGCCGG
ACAACCTGGTCCATACACGCCAGCCATGAATGGATGACGACGGAAGACATGTTGACAGTT
TGGAACAAAGTGTGGATCCTAGAAAATCCATGGATGGAAGACAAAACTCCAGTGGAATCA
TGGGAGGAAATCCCATACCTGGGAAAAAGAGAAGACCAATGGTGCGGCTCACTGATTGGG
CTGACAAGCAGAGCCACCTGGGCGAAGAATATCCAGACAGCAATAAACCAAGTCAGATCC
CTCATTGGCAATGAGGAATACACAGATTACATGCCATCCATGAAAAGATTCAGAAGAGAA
GAGGAAGAGGCAGGAGTTTTGTGGTAG

# Drug_Target_5_General_Function:
Involved in nucleic acid binding

# Drug_Target_5_General_References:
12032088	Egloff MP, Benarroch D, Selisko B, Romette JL, Canard B: An RNA cap (nucleoside-2'-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization. EMBO J. 2002 Jun 3;21(11):2757-68.
12759475	Modis Y, Ogata S, Clements D, Harrison SC: A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):6986-91. Epub 2003 May 20.
12773377	Zhang Y, Corver J, Chipman PR, Zhang W, Pletnev SV, Sedlak D, Baker TS, Strauss JH, Kuhn RJ, Rossmann MG: Structures of immature flavivirus particles. EMBO J. 2003 Jun 2;22(11):2604-13.
2741348	Wright PJ, Cauchi MR, Ng ML: Definition of the carboxy termini of the three glycoproteins specified by dengue virus type 2. Virology. 1989 Jul;171(1):61-7.
2827375	Hahn YS, Galler R, Hunkapiller T, Dalrymple JM, Strauss JH, Strauss EG: Nucleotide sequence of dengue 2 RNA and comparison of the encoded proteins with those of other flaviviruses. Virology. 1988 Jan;162(1):167-80.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
2322

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
379224

# Drug_Target_5_Name:
Genome polyprotein

# Drug_Target_5_Number_of_Residues:
3388

# Drug_Target_5_PDB_ID:
1P58

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF00869	Flavi_glycoprot
PF00948	Flavi_NS1
PF00949	Peptidase_S7
PF00972	Flavi_NS5
PF01002	Flavi_NS2B
PF01003	Flavi_capsid
PF01004	Flavi_M
PF01005	Flavi_NS2A
PF01349	Flavi_NS4B
PF01350	Flavi_NS4A
PF01570	Flavi_propep
PF01728	FtsJ
PF02832	Flavi_glycop_C
PF07652	Flavi_DEAD

# Drug_Target_5_Protein_Sequence:
>Genome polyprotein [Contains: Capsid protein C
MNDQRKKARNTPFNMLKRERNRVSTVQQLTKRFSLGMLQGRGPLKLFMALVAFLRFLTIP
PTAGILKRWGTIKKSKAINVLRGFRKEIGRMLNILNRRRRTAGMIIMLIPTVMAFHLTTR
NGEPHMIVSRQEKGKSLLFKTKDGTNMCTLMAMDLGELCEDTITYKCPFLKQNEPEDIDC
WCNSTSTWVTYGTCTTTGEHRREKRSVALVPHVGMGLETRTETWMSSEGAWKHAQRIETW
ILRHPGFTIMAAILAYTIGTTHFQRVLIFILLTAIAPSMTMRCIGISNRDFVEGVSGGSW
VDIVLEHGSCVTTMAKNKPTLDFELIKTEAKQPATLRKYCIEAKLTNTTTDSRCPTQGEP
TLNEEQDKRFVCKHSMVDRGWGNGCGLFGKGGIVTCAMFTCKKNMEGKIVQPENLEYTVV
ITPHSGEEHAVGNDTGKHGKEVKITPQSSITEAELTGYGTVTMECSPRTGLDFNEMVLLQ
MKDKAWLVHRQWFLDLPLPWLPGADTQGSNWIQKETLVTFKNPHAKKQDVVVLGSQEGAM
HTALTGATEIQMSSGNLLFTGHLKCRLRMDKLQLKGMSYSMCTGKFKVVKEIAETQHGTI
VIRVQYEGDGSPCKTPFEIMDLEKRHVLGRLTTVNPIVTEKDSPVNIEAEPPFGDSYIII
GVEPGQLKLDWFKKGSSIGQMFETTMRGAKRMAILGDTAWDFGSLGGVFTSIGKALHQVF
GAIYGAAFSGVSWTMKILIGVIITWIGMNSRSTSLSVSLVLVGIVTLYLGVMVQADSGCV
VSWKNKELKCGSGIFVTDNVHTWTEQYKFQPESPSKLASAIQKAHEEGICGIRSVTRLEN
LMWKQITSELNHILSENEVKLTIMTGDIKGIMQVGKRSLRPQPTELRYSWKTWGKAKMLS
TELHNQTFLIDGPETAECPNTNRAWNSLEVEDYGFGVFTTNIWLRLREKQDAFCDSKLMS
AAIKDNRAVHADMGYWIESALNDTWKIEKASFIEVKSCHWPKSHTLWSNGVLESEMVIPK
NFAGPVSQHNNRPGYHTQTAGPWHLGKLEMDFDFCEGTTVVVTEDCGNRGPSLRTTTASG
KLITEWCCRSCTLPPLRYRGEDGCWYGMEIRPLKEKEENLVSSLVTAGHGQIDNFSLGIL
GMALFLEEMLRTRVGTKHAILLVAVSFVTLITGNMSFRDLGRVMVMVGATMTDDIGMGVT
YLALLAAFKVRPTFAAGLLLRKLTSKELMMTTIGIVLLSQSSIPETILELTDALALGMMV
LKMVRNMEKYQLAVTIMAILCVPNAVILQNAWKVSCTILAVVSVSPLFLTSSQQKADWIP
LALTIKGLNPTAIFLTTLSRTSKKRSWPLNEAIMAVGMVSILASSLLKNDTPMTGPLVAG
GLLTVCYVLTGRSADLELERATDVKWDDQAEISGSSPILSITISEDGSMSIKNEEEEQTL
TILIRTGLLVISGLFPVSIPITAAAWYLWEVKKQRAGVLWDVPSPPPVGKAELEDGAYRI
KQKGILGYSQIGAGVYKEGTFHTMWHVTRGAVLMHKGKRIEPSWADVKKDLISYGGGWKL
EGEWKEGEEVQVLALEPGKNPRAVQTKPGLFRTNTGTIGAVSLDFSPGTSGSPIVDKKGK
VVGLYGNGVVTRSGAYVSAIAQTEKSIEDNPEIEDDIFRKRRLTIMDLHPGAGKTKRYLP
AIVREAIKRGLRTLILAPTRVVAAEMEEALRGLPIRYQTPAIRAEHTGREIVDLMCHATF
TMRLLSPIRVPNYNLIIMDEAHFTDPASIAARGYISTRVEMGEAAGIFMTATPPGSRDPF
PQSNAPIMDEEREIPERSWNSGHEWVTDFKGKTVWFVPSIKTGNDIAACLRKNGKRVIQL
SRKTFDSEYVKTRTNDWDFVVTTDISEMGANFKAERVIDPRRCMKPVILTDGEERVILAG
PMPVTHSSAAQRRGRIGRNPRNENDQYIYMGEPLENDEDCAHWKEAKMLLDNINTPEGII
PSMFEPEREKVDAIDGEYRLRGEARKTFVDLMRRGDLPVWLAYKVAAEGINYADRRWCFD
GTRNNQILEENVEVEIWTKEGERKKLKPRWLDARIYSDPLALKEFAAGRKSLTLNLITEM
GRLPTFMTQKARDALDNLAVLHTAEAGGKAYNHALSELPETLETLLLLTLLATVTGGIFL
FLMSGRGIGKMTLGMCCIITASILLWYAQIQPHWIAASIILEFFLIVLLIPEPEKQRTPQ
DNQLTYVIIAILTVVAATMANEMGFLEKTKKDLGLGNIATQQPESNILDIDLRPASAWTL
YAVATTFITPMLRHSIENSSVNVSLTAIANQATVLMGLGKGWPLSKMDIGVPLLAIGCYS
QVNPITLTAALLLLVAHYAIIGPGLQAKATREAQKRAAAGIMKNPTVDGITVIDLDPIPY
DPKFEKQLGQVMLLVLCVTQVLMMRTTWALCEALTLATGPVSTLWEGNPGRFWNTTIAVS
MANIFRGSYLAGAGLLFSIMKNTTSTRRGTGNIGETLGEKWKSRLNALGKSEFQIYKKSG
IQEVDRTLAKEGIKRGETDHHAVSRGSAKLRWFVERNLVTPEGKVVDLGCGRGGWSYYCG
GLKNVREVKGLTKGGPGHEEPIPMSTYGWNLVRLQSGVDVFFVPPEKCDTLLCDIGESSP
NPTVEAGRTLRVLNLVENWLNNNTQFCVKVLNPYMPSVIERMETLQRKYGGALVRNPLSR
NSTHEMYWVSNASGNIVSSVNMISRMLINRFTMRHKKATYEPDVDLGSGTRNIGIESETP
NLDIIGKRIEKIKQEHETSWHYDQDHPYKTWAYHGSYETKQTGSASSMVNGVVRLLTKPW
DVVPMVTQMAMTDTTPFGQQRVFKEKVDTRTQEPKEGTKKLMKITAEWLWKELGKKKTPR
MCTREEFTKKVRSNAALGAIFTDENKWKSAREAVEDSRFWELVDKERNLHLEGKCETCVY
NMMGKREKKLGEFGKAKGSRAIWYMWLGARFLEFEALGFLNEDHWFSRENSLSGVEGEGL
HKLGYILREVSKKEGGAMYADDTAGWDTRITIEDLKNEEMITNHMAGEHKKLAEAIFKLT
YQNKVVRVQRPTPRGTVMDIISRRDQRGSGQVGTYGLNTFTNMEAQLIRQMEGEGIFKSI
QHLTASEEIAVQDWLARVGRERLSRMAISGDDCVVKPLDDRFARALTALNDMGKVRKDIQ
QWEPSRGWNDWTQVPFCSHHFHELIMKDGRTLVVPCRNQDELIGRARISQGAGWSLRETA
CLGKSYAQMWSLMYFHRRDLRLAANAICSAVPSHWVPTSRTTWSIHASHEWMTTEDMLTV
WNKVWILENPWMEDKTPVESWEEIPYLGKREDQWCGSLIGLTSRATWAKNIQTAINQVRS
LIGNEEYTDYMPSMKRFRREEEEAGVLW

# Drug_Target_5_Reaction:
nucleoside triphosphate + RNAn = diphosphate + RNAn+1

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
The small proteins NS2A, NS4A and NS4B are hydrophobic, suggesting a possible membrane-related function. NS5 may play a role in the viral RNA replication. The NS2B/NS3 protease complex processes the viral polyprotein

# Drug_Target_5_SwissProt_ID:
P12823

# Drug_Target_5_SwissProt_Name:
POLG_DEN2P

# Drug_Target_5_Synonyms:
Core protein
EC 2.7.7.48
EC 3.4.21.91
Envelope protein M
Flavivirin protease NS2B regulatory subunit
Flavivirin protease NS3 catalytic subunit
Genome polyprotein [Contains: Capsid protein C
Major envelope protein E
Matrix protein
NS1
NS2A
NS4A
NS4B
NS5]
Non- structural protein 1
Non-structural protein 2A
Non-structural protein 4A
Non-structural protein 4B
RNA-directed RNA polymerase

# Drug_Target_5_Theoretical_pI:
8.67

# Drug_Target_5_Transmembrane_Regions:
43-59
101-117
268-284
727-743
757-773

# Drug_Target_6_Cellular_Location:
Not Available

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
PNMT

# Drug_Target_6_GenBank_ID_Gene:
J03727

# Drug_Target_6_GenBank_ID_Protein:
190142

# Drug_Target_6_GeneCard_ID:
PNMT

# Drug_Target_6_Gene_Name:
PNMT

# Drug_Target_6_Gene_Sequence:
>849 bp
ATGAGCGGCGCAGACCGTAGCCCCAATGCGGGCGCAGCCCCTGACTCGGCCCCGGGCCAG
GCGGCGGTGGCTTCGGCCTACCAGCGCTTCGAGCCGCGCGCCTACCTCCGCAACAACTAC
GCGCCCCCTCGCGGGGACCTGTGCAACCCGAACGGCGTCGGGCCGTGGAAGCTGCGCTGC
TTGGCGCAGACCTTCGCCACCGGTGAAGTGTCCGGACGCACCCTCATCGACATTGGTTCA
GGCCCCACCGTGTACCAGCTGCTCAGTGCCTGCAGCCACTTTGAGGACATCACCATGACA
GATTTCCTGGAGGTCAACCGCCAGGAGCTGGGGCGCTGGCTGCAGGAGGAGCCGGGGGCC
TTCAACTGGAGCATGTACAGCCAACATGCCTGCCTCATTGAGGGCAAGGGGGAATGCTGG
CAGGATAAGGAGCGCCAGCTGCGAGCCAGGGTGAAACGGGTCCTGCCCATCGACGTGCAC
CAGCCCCAGCCCCTGGGTGCTGGGAGCCCAGCTCCCCTGCCTGCTGACGCCCTGGTCTCT
GCCTTCTGCTTGGAGGCTGTGAGCCCAGATCTTGCCAGCTTTCAGCGGGCCCTGGACCAC
ATCACCACGCTGCTGAGGCCTGGGGGGCACCTCCTCCTCATCGGGGCCCTGGAGGAGTCG
TGGTACCTGGCTGGGGAGGCCAGGCTGACGGTGGTGCCAGTGTCTGAGGAGGAGGTGAGG
GAGGCCCTGGTGCGTAGTGGCTACAAGGTCCGGGACCTCCGCACCTATATCATGCCTGCC
CACCTTCAGACAGGCGTAGATGATGTCAAGGGCGTCTTCTTCGCCTGGGCTCAGAAGGTT
GGGCTGTGA

# Drug_Target_6_General_Function:
Involved in methyltransferase activity

# Drug_Target_6_General_References:
2835776	Baetge EE, Behringer RR, Messing A, Brinster RL, Palmiter RD: Transgenic mice express the human phenylethanolamine N-methyltransferase gene in adrenal medulla and retina. Proc Natl Acad Sci U S A. 1988 May;85(10):3648-52.
3372503	Kaneda N, Ichinose H, Kobayashi K, Oka K, Kishi F, Nakazawa A, Kurosawa Y, Fujita K, Nagatsu T: Molecular cloning of cDNA and chromosomal assignment of the gene for human phenylethanolamine N-methyltransferase, the enzyme for epinephrine biosynthesis. J Biol Chem. 1988 Jun 5;263(16):7672-7.

# Drug_Target_6_HGNC_ID:
HGNC:9160

# Drug_Target_6_HPRD_ID:
07176

# Drug_Target_6_ID:
974

# Drug_Target_6_Locus:
17q21-q22

# Drug_Target_6_Molecular_Weight:
30855

# Drug_Target_6_Name:
Phenylethanolamine N-methyltransferase

# Drug_Target_6_Number_of_Residues:
282

# Drug_Target_6_PDB_ID:
1N7J

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF01234	NNMT_PNMT_TEMT

# Drug_Target_6_Protein_Sequence:
>Phenylethanolamine N-methyltransferase
MSGADRSPNAGAAPDSAPGQAAVASAYQRFEPRAYLRNNYAPPRGDLCNPNGVGPWKLRC
LAQTFATGEVSGRTLIDIGSGPTVYQLLSACSHFEDITMTDFLEVNRQELGRWLQEEPGA
FNWSMYSQHACLIEGKGECWQDKERQLRARVKRVLPIDVHQPQPLGAGSPAPLPADALVS
AFCLEAVSPDLASFQRALDHITTLLRPGGHLLLIGALEESWYLAGEARLTVVPVSEEEVR
EALVRSGYKVRDLRTYIMPAHLQTGVDDVKGVFFAWAQKVGL

# Drug_Target_6_Reaction:
S-adenosyl-L-methionine + phenylethanolamine = S-adenosyl-L-homocysteine + N-methylphenylethanolamine

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Converts noradrenaline to adrenaline

# Drug_Target_6_SwissProt_ID:
P11086

# Drug_Target_6_SwissProt_Name:
PNMT_HUMAN

# Drug_Target_6_Synonyms:
EC 2.1.1.28
Noradrenaline N-methyltransferase
PNMTase

# Drug_Target_6_Theoretical_pI:
5.96

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Cytoplasm

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
U34637

# Drug_Target_7_GenBank_ID_Protein:
1006799

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
cmaA2

# Drug_Target_7_Gene_Sequence:
>969 bp
ATGCCGATGCAACGGTGGCGGCGATTGCATCGATCTAGTGGGGAAAGTAGGGTCCGTTCA
ATGACGTCACAGGGCGACACGACAAGCGGCACGCAGCTCAAGCCGCCGGTCGAAGCAGTT
CGATCCCACTACGACAAATCGAACGAGTTCTTCAAGCTCTGGCTTGACCCATCGATGACG
TACAGCTGCGCCTACTTCGAACGTCCCGATATGACGCTGGAAGAGGCGCAGTACGCGAAG
CGCAAGCTGGCACTGGACAAGCTGAACCTTGAGCCCGGCATGACGCTGCTCGACATCGGC
TGCGGCTGGGGTTCCACCATGCGACACGCGGTCGCCGAGTACGACGTCAACGTCATCGGC
TTGACCCTGAGCGAAAACCAGTACGCCCACGACAAGGCGATGTTCGATGAGGTCGACAGC
CCCCGCCGAAAAGAGGTGCGAATCCAGGGCTGGGAGGAGTTCGACGAGCCGGTCGACCGC
ATCGTGTCACTCGGTGCGTTTGAGCATTTCGCCGACGGTGCCGGGGACGCCGGGTTCGAG
CGCTACGACACCTTCTTCAAGAAGTTCTACAATTTGACGCCCGACGACGGCCGGATGCTG
CTGCACACCATCACTATCCCGGACAAAGAGGAAGCCCAGGAGCTGGGCTTGACGTCTCCG
ATGAGCCTGCTGCGCTTCATCAAGTTCATCCTGACCGAGATCTTCCCGGGCGGGCGGCTG
CCCAGGATCTCGCAGGTGGACTATTACTCCTCCAACGCCGGATGGAAGGTCGAGCGCTAC
CACCGGATCGGGGCCAACTACGTGCCGACCCTGAACGCCTGGGCGGATGCGCTACAGGCG
CACAAAGATGAGGCGATCGCCCTCAAGGGCCAGGAGACGTACGACATCTACATGCACTAC
CTACGTGGCTGCTCAGACCTGTTCCGCGACAAGTACACGGACGTCTGCCAGTTCACTCTG
GTCAAATAA

# Drug_Target_7_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_7_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
7592990	George KM, Yuan Y, Sherman DR, Barry CE 3rd: The biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Identification and functional analysis of CMAS-2. J Biol Chem. 1995 Nov 10;270(45):27292-8.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
2242

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
34660

# Drug_Target_7_Name:
Cyclopropane-fatty-acyl-phospholipid synthase 2

# Drug_Target_7_Number_of_Residues:
302

# Drug_Target_7_PDB_ID:
1KPI

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF02353	CMAS

# Drug_Target_7_Protein_Sequence:
>Cyclopropane-fatty-acyl-phospholipid synthase 2
MTSQGDTTSGTQLKPPVEAVRSHYDKSNEFFKLWLDPSMTYSCAYFERPDMTLEEAQYAK
RKLALDKLNLEPGMTLLDIGCGWGSTMRHAVAEYDVNVIGLTLSENQYAHDKAMFDEVDS
PRRKEVRIQGWEEFDEPVDRIVSLGAFEHFADGAGDAGFERYDTFFKKFYNLTPDDGRML
LHTITIPDKEEAQELGLTSPMSLLRFIKFILTEIFPGGRLPRISQVDYYSSNAGWKVERY
HRIGANYVPTLNAWADALQAHKDEAIALKGQETYDIYMHYLRGCSDLFRDKYTDVCQFTL
VK

# Drug_Target_7_Reaction:
S-adenosyl-L-methionine + phospholipid olefinic fatty acid = S-adenosyl-L-homocysteine + phospholipid cyclopropane fatty acid

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Transfers a methylene group from S-adenosyl-L-methionine to the cis double bond of an unsaturated fatty acid chain resulting in the replacement of the double bond with a methylene bridge. Mycolic acids, which represent the major constituent of mycobacterial cell wall complex, act as substrates

# Drug_Target_7_SwissProt_ID:
P0A5P0

# Drug_Target_7_SwissProt_Name:
CMAS2_MYCTU

# Drug_Target_7_Synonyms:
CFA synthase
Cyclopropane fatty acid synthase
Cyclopropane mycolic acid synthase 2
EC 2.1.1.79

# Drug_Target_7_Theoretical_pI:
4.91

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Cytoplasmic

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
X16456

# Drug_Target_8_GenBank_ID_Protein:
46455

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
rsrIM

# Drug_Target_8_Gene_Sequence:
>960 bp
ATGGCAAACCGATCTCACCACAATGCGGGCCACCGAGCGATGAACGCTCTCCGCAAGTCA
GGCCAAAAGCATTCGTCCGAGTCTCAGTTGGGATCTTCGGAGATCGGAACCACACGACAT
GTGTATGACGTTTGCGATTGCCTCGACACCTTGGCGAAGCTGCCCGACGACTCCGTCCAG
TTGATCATTTGTGATCCTCCATACAACATCATGCTGGCGGACTGGGATGATCACATGGAC
TACATCGGCTGGGCGAAGCGATGGCTAGCCGAAGCCGAGCGTGTTCTATCCCCAACGGGC
AGCATAGCGATTTTCGGCGGCCTACAATACCAAGGGGAGGCTGGTTCAGGTGATCTGATC
TCAATCATTTCGCACATGAGACAAAACAGCAAAATGCTGCTCGCAAACCTTATCATCTGG
AACTATCCGAACGGCATGAGTGCGCAGCGCTTCTTTGCAAATAGGCACGAGGAAATCGCG
TGGTTCGCCAAGACCAAGAAGTATTTCTTCGATCTTGACGCTGTGCGGGAACCATATGAC
GAGGAAACCAAAGCCGCTTACATGAAGGACAAGCGGTTGAACCCTGAGTCGGTTGAAAAG
GGACGCAACCCAACAAACGTGTGGCGGATGTCTCGGCTTAACGGCAATTCTCTTGAACGT
GTCGGCCACCCCACGCAAAAACCAGCCGCAGTGATTGAGAGACTGGTTCGCGCGTTGTCG
CATCCGGGTTCAACGGTCCTCGATTTTTTTGCTGGAAGTGGGGTAACGGCGCGCGTTGCA
ATTCAAGAGGGACGGAACAGCATTTGCACTGACGCCGCGCCTGTATTCAAAGAATATTAC
CAGAAGCAGCTAACTTTCCTTCAAGATGATGGACTGATCGACAAAGCGCGATCATATGAA
ATTGTTGAAGGGGCTGCGAACTTTGGTGCAGCATTGCAGCGGGGAGATGTTGCTTCATAA

# Drug_Target_8_General_Function:
Replication, recombination and repair

# Drug_Target_8_General_References:
11024175	Scavetta RD, Thomas CB, Walsh MA, Szegedi S, Joachimiak A, Gumport RI, Churchill ME: Structure of RsrI methyltransferase, a member of the N6-adenine beta class of DNA methyltransferases. Nucleic Acids Res. 2000 Oct 15;28(20):3950-61.
2602165	Stephenson FH, Greene PJ: Nucleotide sequence of the gene encoding the RsrI methyltransferase. Nucleic Acids Res. 1989 Dec 25;17(24):10503.
2690017	Kaszubska W, Aiken C, O'Connor CD, Gumport RI: Purification, cloning and sequence analysis of RsrI DNA methyltransferase: lack of homology between two enzymes, RsrI and EcoRI, that methylate the same nucleotide in identical recognition sequences. Nucleic Acids Res. 1989 Dec 25;17(24):10403-25.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
2653

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
35656

# Drug_Target_8_Name:
Modification methylase RsrI

# Drug_Target_8_Number_of_Residues:
319

# Drug_Target_8_PDB_ID:
1NW7

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF01555	N6_N4_Mtase

# Drug_Target_8_Protein_Sequence:
>Modification methylase RsrI
MANRSHHNAGHRAMNALRKSGQKHSSESQLGSSEIGTTRHVYDVCDCLDTLAKLPDDSVQ
LIICDPPYNIMLADWDDHMDYIGWAKRWLAEAERVLSPTGSIAIFGGLQYQGEAGSGDLI
SIISHMRQNSKMLLANLIIWNYPNGMSAQRFFANRHEEIAWFAKTKKYFFDLDAVREPYD
EETKAAYMKDKRLNPESVEKGRNPTNVWRMSRLNGNSLERVGHPTQKPAAVIERLVRALS
HPGSTVLDFFAGSGVTARVAIQEGRNSICTDAAPVFKEYYQKQLTFLQDDGLIDKARSYE
IVEGAANFGAALQRGDVAS

# Drug_Target_8_Reaction:
S-adenosyl-L-methionine + DNA adenine = S-adenosyl-L-homocysteine + DNA 6-methylaminopurine

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
This methylase recognizes the double-stranded sequence GAATTC, causes specific methylation on A-? on both strands, and protects the DNA from cleavage by the RsrI endonuclease

# Drug_Target_8_SwissProt_ID:
P14751

# Drug_Target_8_SwissProt_Name:
MTR1_RHOSH

# Drug_Target_8_Synonyms:
Adenine-specific methyltransferase RsrI
EC 2.1.1.72
M.RsrI

# Drug_Target_8_Theoretical_pI:
7.06

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Cytoplasmic

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
Not Available

# Drug_Target_9_Essentiality:
Non-Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
AE000512

# Drug_Target_9_GenBank_ID_Protein:
Not Available

# Drug_Target_9_GeneCard_ID:
Not Available

# Drug_Target_9_Gene_Name:
TM_0488

# Drug_Target_9_Gene_Sequence:
>849 bp
ATGGACACCAGAAAGAATGTCTCCGGAGCTGAGAGAAAAATTTGGAGTCTGATAAGAGAC
TGCTCTGGAAAACTCGAGGGAGTGACCGAAACTTCTGTTCTTGAGGTGTTACTCATCGTT
TCCCGGGTGCTTGGGATCCGCAAGGAAGATCTCTTTTTGAAAGACCTGGGAGTTTCTCCA
ACTGAGGAAAAAAGGATTCTGGAACTCGTGGAGAAAAGAGCAAGTGGATATCCCCTGCAC
TATATCCTCGGTGAGAAAGAGTTCATGGGCCTTTCTTTCCTCGTGGAAGAAGGCGTTTTT
GTTCCAAGGCCGGAGACGGAGGAACTGGTCGAACTCGCCCTCGAGCTGATAAGAAAGTAC
GGAATAAAGACAGTCGCAGACATAGGAACAGGAAGCGGAGCCATTGGAGTGAGCGTTGCG
AAGTTCTCCGATGCGATCGTTTTCGCGACGGACGTTTCTTCCAAAGCCGTTGAAATCGCC
AGAAAAAACGCGGAAAGACACGGTGTTTCCGACAGATTCTTTGTGAGAAAAGGTGAGTTT
CTTGAACCGTTCAAAGAAAAATTCGCATCGATCGAGATGATCCTTTCGAATCCTCCATAC
GTGAAATCGAGTGCTCATCTGCCAAAAGATGTTCTTTTCGAGCCTCCAGAGGCACTTTTT
GGAGGAGAGGACGGTCTTGACTTTTACAGAGAATTTTTCGGCAGGTACGATACGAGCGGA
AAGATTGTGCTGATGGAGATAGGAGAAGACCAGGTGGAGGAGTTGAAAAAGATCGTTTCC
GACACTGTTTTCCTGAAGGATTCCGCCGGAAAGTACCGTTTTCTCCTTCTCAACCGGCGT
TCCTCTTGA

# Drug_Target_9_General_Function:
Involved in protein methyltransferase activity

# Drug_Target_9_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.
12741815	Schubert HL, Phillips JD, Hill CP: Structures along the catalytic pathway of PrmC/HemK, an N5-glutamine AdoMet-dependent methyltransferase. Biochemistry. 2003 May 20;42(19):5592-9.

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
4306

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
31610

# Drug_Target_9_Name:
HemK protein

# Drug_Target_9_Number_of_Residues:
282

# Drug_Target_9_PDB_ID:
1SG9

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF06325	PrmA

# Drug_Target_9_Protein_Sequence:
>HemK protein
MDTRKNVSGAERKIWSLIRDCSGKLEGVTETSVLEVLLIVSRVLGIRKEDLFLKDLGVSP
TEEKRILELVEKRASGYPLHYILGEKEFMGLSFLVEEGVFVPRPETEELVELALELIRKY
GIKTVADIGTGSGAIGVSVAKFSDAIVFATDVSSKAVEIARKNAERHGVSDRFFVRKGEF
LEPFKEKFASIEMILSNPPYVKSSAHLPKDVLFEPPEALFGGEDGLDFYREFFGRYDTSG
KIVLMEIGEDQVEELKKIVSDTVFLKDSAGKYRFLLLNRRSS

# Drug_Target_9_Reaction:
Not Available

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
Not Available

# Drug_Target_9_SwissProt_ID:
Q9WYV8

# Drug_Target_9_SwissProt_Name:
Q9WYV8_THEMA

# Drug_Target_9_Synonyms:
Not Available

# Drug_Target_9_Theoretical_pI:
5.19

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB01752
